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ABSTRACT OF THE DISSERTATION
Isotope Harvesting at Heavy-Ion Fragmentation Facilities
By
Tara Mastren
Doctor of Philosophy in Chemistry
Washington University in St. Louis, 2014
Dr. Suzanne E. Lapi, Co-Chair
Dr. Lee G. Sobotka, Co-Chair

Isotope harvesting from heavy-ion fragmentation facilities is a potential source of
isotopes of interest for applications research. With the upgrade of the National Superconducting
Cyclotron Laboratory (NSCL) to the Facility for Rare Isotope Beams (FRIB) usable quantities of
many isotopes of interest will be produced and available for harvest from an aqueous beam
dump. If available, these isotopes would be of interest to a broad range of applications such as
medicine, geology, and stockpile stewardship. Preliminary experiments were performed at the
NSCL in order to determine the feasibility of isotope harvesting at (FRIB).
A water target station that consisted of a 100 mL beam dump was designed and built to
collect secondary beams at the NSCL. This target station could be controlled remotely from
outside of the experimental vault allowing for multiple collections with minimal exposure to
radioactivity. Three secondary beam collections were made with the water target station: a 24Na
beam, an analyzed 67Cu beam, and an unanalyzed 67Cu beam.

ix

To test the durability of the target station, a 73% pure 85 MeV/u 24Na secondary beam
was stopped and collected in the beam dump. Multiple collections were made with currents up
to 2 x 106 particles per second without visible radiolytic damage to the target cell. The station
operated without any observed release of radiolytic gases, spills, or loss of radioactive liquids.
The water target station was then used collect a 77% pure 76 MeV/u 67Cu secondary
beam.

67

Cu was separated from the other secondary beam contaminants with an average

recovery of 88 ± 3 % and used to radiolabel an antibody. The radiochemical yield of 67CuNOTA-Bz-NCS-Trastuzumab was >95%.
To better mimic the conditions that would be present in the beam dump at FRIB an
unanalyzed beam was collected. This secondary beam was 2.6% pure and contained many
contaminants most of which are located in period four of the periodic table.

67

Cu was separated

from the beam contaminants with an average recovery of 74 ± 4% and a radiochemical purity of
>99%. The purified 67Cu was then used to radiolabel NOTA conjugated Panitumumab
antibodies and injected into HCT-116 tumor bearing mice via tail vein injection. A five day
biodistribution profile was obtained and the tumor uptake of 67Cu-NOTA-Bz-NCS-Panitumumab
was measured to be 12.5 ± 0.7 % ID/g.

x

Chapter 1
Introduction

1

Nuclear Chemistry and its Applications in Medicine
Radioisotopes have been very important for the advancement of cancer imaging and
treatment. Single Photon Emission Computed Tomography (SPECT) and Positron Emission
Tomography (PET), which detect administered radiotracers in the body, have become routine
imaging modalities in cancer assessment.1-3 Additionally, advancements in radiotherapy now
involve targeting cancers with therapeutic radioisotopes so that the radiation treatment is
delivered directly to the tumor, reducing radioactive exposure to healthy cells.7,8 The nuclear
properties, availability, and chemistry of the radioisotopes all have to be considered when
designing tracers for the above techniques.

Nuclear Chemistry
Nuclear Decay (β+, β-, and γ)
The chart of the nuclides, a map of all known nuclei with the number of protons (Z)
displayed on the ordinate and neutron number (N) on the abscissa, is shown in Figure 1-1.
Understanding of this playfield of nuclear science requires understanding a suppressed third axis
– mass. The minimum mass as a function of mass number, A= Z+N, forms a mass valley
populated by the stable isotopes. Isobars (A = constant) not at the bottom of the valley are on the
(mass) valley walls and beta decay (via the isobar conserving weak interaction) to the stable
nuclei at the valley bottom. Isotopes on the left side of stability (North-West on the diagonal
isobar) are proton rich and decay by electron capture (ε) and/or positron emission (β+). Isotopes
on the right side of stability (South-East) are neutron rich and decay by electron emission (β-).
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Figure 1-1. Chart of the Nuclides.4

Positron emission happens when a proton within the nucleus (indicated by the quotes in
Equation (1)) of an atom is converted into a neutron by the emission of a positron and a neutrino
(Equation 1) thus keeping the mass number the same and decreasing the atomic number by 1.
An example of an isotope that undergoes positron decay is 18F (Equation 2). The emitted
positron thermalizes by electrostatic interactions with electrons, typically traveling 1-3mm
before annihilating with an electron creating two 511 keV photons travelling at approximately
180º from each other (Figure 1-2). The Q-value makes the equations energy balanced and is the
energy equivalent of the mass difference of the left and right sides of the arrow. For positron
decay to occur, the atomic mass difference must be at least 1.022 MeV otherwise the decay will
occur via electron capture which is discussed below. Note that the Q-value has the opposite sign
“p”
18F

“n” + β+ + ν + Q

(1)

+ β+ + ν + Q

(2)

18O-

3

Figure 1-2. Positron decay and the resulting annihilation with an electron creating two 511
keV gamma rays approximately 180º apart.

convention as reaction enthalpies and is always provided on a unit basis rather than per mole of
conversions. In spontaneous decays, the Q-value is always positive. Electron capture, which
competes with positron decay, converts a proton into a neutron by capturing an inner-shell
electron (Equation 3) also keeping the mass number the same, decreasing the atomic number by
1 and emitting a neutrino. An example of an isotope that undergoes electron capture is 49V
(Equation 4).
“p” + e49V+

+ e-

“n” + ν + Q
49Ti

(3)

+ν+Q

(4)

β- decay occurs when a neutron within the nucleus of an atom is converted into a proton
by the emission of an electron and an antineutrino (Equation 5) thus keeping the mass number
the same and increasing the atomic number by 1. As the neutron is more massive than the proton
plus an electron, the decay represented in Equation 5 without the quotes does occur

4

spontaneously with a Qn = 0.78 MeV. An example of an isotope relevant for medicine that
undergoes β- decay is 99Mo (Equation 6).
“n”
99Mo

“p” + β- + ν +Q
99mTc

(5)

+ β- + ν + Q

(6)

When isotopes undergo the different types of β decay, they often decay to an excited state
in the daughter nucleus. When this happens the nucleus decays to the ground state by the
emission of one or several photons of discrete energy (γ decay) or by the emission of an orbital
electron, which is called an internal-conversion electron.10 This is the case in the above decay in
Equation 6 where 99Mo decays to an excited state in 99Tc, 99mTc, which after emission of an
internal-conversion electron, with a kinetic energy of 2.2 keV minus the binding energy of the
electron thereby decaying to another excited state in 99Tc, then decays to the ground state, 99gTc,
usually by emitting a 140.5 keV gamma ray. The atomic and mass numbers (Z and A) of the
decaying atom remains unchanged in γ decay.
The decay properties for a specific radioisotope can be shown through a decay scheme.
Decay schemes provide information on the type of decay, branching ratios to the different energy
levels in the daughter nucleus, and the intensity and occurrence of the gamma rays from the

Figure 1-3. The 137Cs decay scheme.4 In this case, photon emission from the state populated
95% of the time in beta decay, decays to the ground state 85.1% of the time by the emission
of a photon, the remainder of the deexcitations within the daughter 137Ba are by the internalconversion process.
5

excited states, populated by the beta decay of the parent atom, to the ground state of the
daughter.10,11 An example decay scheme is shown for 137Cs in Figure 1-3.4

Positron Emission Tomography (PET)
Positron Emission Tomography (PET) is a common imaging modality used for
diagnostic imaging in oncology, cardiology and neurology. PET takes advantage of the
approximate collinearity of the annihilation photons resulting from β+ decay. In a PET scanner,
scintillation crystals are positioned in a ring around the patient. The event is detected through
the coincidence detection of the two 511keV photons that are detected at the same time and
across the ring. Algorithms are then used to reconstruct an image from the intersection of the
lines from different decays (Figure 1-4).
The two main factors that limit the resolution of this method are non-collinearity,
resulting from non-zero momentum from the positron-electron pair before the annihilation, and
that the annihilation point is remote from that of the original radioactive decay. Since β+ decay is
a three-body final state as shown in Equations (1) and (2), the energy of an emitted positron is
not discrete but rather a spectrum of energies. The positron energy distribution is therefore
usually characterized by either E(β+mean) or E(β+max) with the mean positron energy about one
third of the maximum energy for light nuclei. The E(β+max) limits the resolution of this imaging
modality because higher energy positrons travel further in the tissue before reaching thermal
energies where the probability of annihilation with an e- is maximal. Algorithms have been
created to decrease the effect from these factors and improve the overall resolution.12,13
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Figure 1-4. Schematic of Positron Emission Tomography (PET).
The most common PET radiopharmaceutical is [18F]FDG (2-[18F]Fluoro-2-deoxyglucose)
(Figure 1-5 A) and has been used in cancer detection for more than twenty-five years.14 As a
glucose derivative [18F]FDG’s mechanism of action is through the glycolytic pathway. Unlike
glucose (Figure 1-5 B), once [18F]FDG is taken up by the cells and converted into 2-[18F]fluoro2-deoxyglucose-6-phosphate it cannot undergo further catabolism due to the lack of oxygen at
the C-2 carbon thus it becomes trapped inside the cell.14,15 Due to the high glycolytic rate of

Figure 1-5. Structures of A 2-[18F]Fluoro-2-deoxyglucose and B Glucose. The C-2 carbon
(counting from the internal ether O) is bonded to the positron emitting radionuclide 18F.

7

cancer cells, [18F]FDG accumulation is typically higher in cancer cells than normal cells which
makes it an optimal imaging agent for cancer detection based on metabolic function.
Single Photon Emission Computed Tomography (SPECT)
Single Photon Emission Computed Tomography (SPECT) is the most common nuclear
medicine imaging modality. Radionuclides that are good for SPECT imaging typically decay
with the emission of a low-energy gamma ray (~140 keV). In SPECT imaging one or more
scintillation cameras rotate around the patient taking multiple two-dimensional projections that
are then compiled to make a three-dimensional image with the use of algorithms taking
advantage of the isotropic emission pattern of γ rays from nuclei existing under normal
conditions (e.g. not employing ultra-low T and high magnetic fields) (Figure 1-6).

Figure 1-6. Schematic of Single Photon Emission Computed Tomography (SPECT).
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A limitation of SPECT imaging is the need for collimators in order to determine the angle
of incidence. These collimators reject photons that are outside a very small angular window.
Because of this limitation, a larger amount of activity must be injected in order to achieve an
image which is a major disadvantage as compared to the higher sensitivity of PET imaging.12,13
99m

Tc is the most widely used radionuclide in nuclear medicine and SPECT imaging has

been optimized to accommodate the 140.5 keV gamma ray resulting from the decay of 99mTc as
described earlier. One of the most common scans involving 99mTc is a bone scan which employs
the radiopharmaceutical 99mTc-diphosphonate. Increased 99mTc-diphosphonate uptake can
signify diseases such as certain types of bone metastases, osteomyelitis and arthritis, where
decreased uptake signifies lytic lesions or tumor necrosis.16

Properties of Important Isotopes Presented in this Work
The isotopes and their decay properties discussed in this work are listed in Table 1.
68

Ga, and 55Co were made at Washington University School of Medicine.17

24

64

Cu,

Na and 67Cu were

obtained from the National Superconducting Cyclotron Laboratory (NSCL) at Michigan State
University.18 The remaining isotopes listed in the table are side products.
Table 1-1. Properties of isotopes discussed
Isotope Half-Life Decay
βmax(MeV) Associated Gammas (keV)
24
Na
14.97h
β
1.39
1369, 2754
55
Co
17.53h
β+ (76%), ε (24%)
1.50
931, 477, 1408
57
Co
271.8d
ε (100%)
122, 136
57
Ni
35.6h
β+ (43.6%), ε (56.4%)
0.865
1378, 127, 1919
64
+
+
Cu
12.7h
β (17.6%), ε (43.9%),
β (0.653),
1346
β- (38.5)
β-(0.579)
67
Cu
2.58d
β0.562
185, 93.3, 91.3
68
+
Ga
1.13h
β (88.9%), ε (11.1%)
1.90
1077
Data was obtained from the National Nuclear Data Center, Brookhaven National Laboratory,
Upton, NY. Website: http://www.nndc.bnl.gov/chart/chartNuc.jsp4
Imaging and Therapeutic Applications of Radioisotopes
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As discussed above, the gamma rays emitted from the decaying atom (either from the
nucleus or annihilation photons) can be used for PET or SPECT imaging depending on the type
of decay. In order to be useful for imaging, these isotopes need to be delivered to the target of
interest, for example cancer cells. This requires different chemistries to incorporate the
radioisotope onto a targeting probe (i.e. small molecules, antibodies, peptides, or nanoparticles).
For radiometals this can be achieved by conjugating the probe with a chelate that has a high
affinity for the isotope of interest. In this work we will discuss two chelators with high affinity
for copper and cobalt.
In addition to imaging, radioactive decay can be employed for use in cancer therapy. βparticles are of considerable interest for cancer therapy due to the increased linear energy transfer
(LET) to the tissue being irradiated compared to gamma irradiation. Positrons have similar
linear energy transfer to β-, however this decay mode is not of interest for therapy for two
reasons: the accompanying 511 keV gamma rays and the competition with electron capture.
Beta particles travel about 1-3 mm in tissue effectively depositing all of their energy in a small
distance causing damage to the nearby cells. To achieve this therapeutic effect, the radioisotopes
must be delivered very close to the targeted tissue. An example of a therapeutic isotope often
used in medicine is 90Y with Q = 2.28 MeV, average β- energy of 0.937 MeV, and an average
range of 2.5mm in tissue.19,20

Antibodies for use in Cancer Imaging and Therapy
One class of molecular probes used for both cancer imaging and therapy is antibodies.
Antibodies by themselves can be therapeutic and several are FDA approved for therapy.21
Radiolabeling these antibodies with a therapeutic isotope can increase the therapeutic dose
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delivered to the target tissue.22-24 The incorporation of radiometal isotopes onto the antibody of
interest is typically achieved by the use of chelators that are conjugated onto the antibody. Two
popular chelates conjugated onto antibodies for radiometal incorporation are DOTA (1,4,7,10tetraazacyclododecane-1,4,7,10-tetraacetic acid) and NOTA (1,4,7-triazacyclononane-N,N',N"triacetic acid) (Figure 1-7A, B). The conjugation is typically achieved through an NCS group
that is incorporated onto the chelate. The NCS group reacts with exposed lysine groups on the
antibody (Figure 1-7C). Both NOTA and DOTA chelates can be used to incorporate radioactive
copper and cobalt atoms, however, NOTA has been shown to lead to more stable copper
conjugates than DOTA.25,26

Figure 1-7. A DOTA-bz-NCS, B NOTA-bz-NCS, and C Conjugation of DOTA-bz-NCS to
lysine residue on an antibody (Y).

Once an antibody is radiolabeled it can be injected into tumor bearing mice for preclinical
studies or into patients for clinical assessment. Following this, tumor accumulation can be
11

determined through imaging (both preclinical and clinical) and/or biodistribution (preclinical,
Figure 1-8). Tumor imaging using PET or SPECT gives a picture of where the radioisotope
goes in the body and helps determine the time at which the best tumor to non-target contrast can
be achieved. Standard uptake values (SUV) are used to quantify the amount of the radioisotope
that was delivered to the tumor or other non-target organs by taking the activity measured
through PET or SPECT imaging and dividing by the total injected dose per body weight.
Biodistribution data is obtained by sacrificing the mice and performing a dissection to determine
the radioactivity uptake by different organs. This information is typically provided as %ID/g (%
Injected Dose per gram). With these two methods, radiotracers can be developed that lead to the
highest tumor uptake with the smallest achievable dose to non-target tissues.

Figure 1-8. Purified radioisotope is added to a NOTA conjugated antibody to produce a
radiopharmaceutical and that is then injected into tumor bearing mice. After some
predetermined amount of time (usually 3-5 days for antibodies) animals are sacrificed,
dissected and their organs and tumors are measured for radioactivity.

Heavy Ion Fragmentation Facilities
At several nuclear-physics research facilities, heavy-ion beams are generated and are
used to bombard light element targets, like berylium or carbon, to produce secondary radioactive
ion beams (usually by fragmentation reactions). These secondary beams can be used to study
nuclear reactions involving reactants outside of the beta-stable region (higher up on the mass
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valley walls as discussed earlier). These secondary reactions inform on the structure of nuclei
with unusal n/p combinations, structure that, can dictate how elements are made in the first place
- nucleosynthesis. Typically the end user is interested in one radioactive ion that was produced
in the first reaction and the other isotope products created go to waste. Finding methods to
“harvest” these unused isotopes is of considerable interest for applied research in medicine,
stockpile stewardship, geology, and astrophysics.

National Superconducting Cyclotron Laboratory
The National Superconducting Cyclotron Laboratory (NSCL) is a heavy-ion
fragmentation facility located at Michigan State University (MSU). Two cyclotrons in series, a
K500 and a K1200, are used to accelerate heavy ions that are fragmented using a berylium target.
(The K number is the collection of constants that, if there were no other limitations, would be the
maximum proton energy.) An illustration of the fragmentation process is shown in Figure 1-9.
After fragmentation, the isotopes are passed through the A1900 fragment separator27 which
selects the isotope of interest to an end user by employing two pairs of dipole magnets with an
interviening wedge absorber that reduces the energy of the ions differently depending on their
atomic number. Several quadrupole focusing magnets are also employed in the A1900 to achieve

Figure 1-9. Illustration of heavy ion beam fragmentation. Note that isotopes created are not
separated in physical space and can only be separated in the A1900 by magnetic rigidity.
13

high transmission of the desired ion. The secondary beam is then sent to one of many vaults for
nuclear-physics research. Figure 1-10 shows a schematic of the NSCL. A code called LISE++
can be used to simulate the primary fragmentation reaction and to detemine the optimal
parameters for the magnets and wedge absorber to select the desired beam with maximal purity
and to assess the contaminants in the beam.28

Figure 1-10. Schematic of the NSCL located at Michigan State University9

Upgrade to the Facility for Rare Isotope Beams
The NSCL is currently undergoing an upgrade to become the Facility for Rare Isotope
Beams (FRIB) (Figure 1-11). FRIB will replace the two cyclotrons currently in operation at the
NSCL with a linear accelerator. The new facility will be able to increase the energy of the
heavy-ion beams available along with increasing the current by three orders of magnitude.29
With the capability to fragment one thousand times more ions, an aqueous beam dump will be
employed to collect the isotopes that are not wanted for the end user’s experiments. This
dramatically increases the potential for harvesting and has piqued the interest of several
communities.
14

Figure 1-11. Schematic of the Facility for Rare Isotope Beams at Michigan State University6

Harvesting Isotopes of Interest from an Aqueous Beam Dump at FRIB
Many isotopes of interest will be available in usable quantities for harvest from the
aqueous beam dump at FRIB.30 A committee of users from the isotope community was formed
to generate an initial list of isotopes of interest for a large range of scientific applications (Table
1-2). As part of this thesis work, proof-of-principal experiments were performed in order to
develop strategies for the online harvesting of isotopes from the aqueous beam dump at FRIB so
that optimal accomodation for harvesting can be made during the construction of the new
facility. In order to perform these proof-of-principal experiments, a mock beam dump was
designed and built to collect secondary radioisotope beams at the NSCL. Additionally,
separation strategies were developed to determine feasibility, purity, and efficiency of separating
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the isotopes of interest from the other activities in the aqueous beam dump. Preliminary
experiments designed to address some of these concepts will be discussed in this thesis.

Table 1-2. Isotopes of interest for isotope harvesting.
Isotope
Decay Mode Half-Life Application
32
β162y
Tracer; geology, botany
Si
44
48

ε
β+,ε

Ti

59.2y

Medicine, astrophysics, Nuclear Structure

15.98d

Stockpile Stewardship, Medicine

β

-

2.6d

Medicine

Kr
147
Eu-154Eu

β

-

211

Rn

α

10.76y
24d-37y
14.6h

Astrophysics, Stockpile Stewardship
Stockpile Stewardship
Medicine

Ra

β-

14.9d

Medicine, Electric Dipole Moment

Ac

α

10.0d

Medicine

67

V

Cu

85

225
225

Radioisotope Production Using Small Medical Cyclotrons
The use of low-energy cyclotrons to produce isotopes at medical facilities has been
increasing, largely due to the FDA approval of [18F]FDG as previously discussed. These
cyclotrons usually accelerate protons (some also accelerate deuterons and/or alpha particles) and
typically range in proton energy from 11-30 MeV. A cyclotron works by accelerating charged
protons, for example H+ or H-, using an AC modulated electric field and a single large dipole
magnet (schematic shown in Figure 1-12). In the classical (as developed by E. Lawrence in the
early 1930’s) cyclotron there are two dees in which the ions are shielded from the electric field
when they travel through them. Once a proton exits the inner edge of the dee it was traveling in,
an accelerating electric field is sensed across the gap (between the dees) causing the proton to
accelerate across the gap.10,31 The protons travel in a circular path characteristic of a charged
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particle moving in a constant magnetic field, imposed by the dipole. As the ions increase in
speed, the circular path increases in diameter and a spiral trajectory results. (One can view a
cyclotron as a linear accelerator made efficient in space and energy by the reuse, on each turn, of
the same set of accelerating gaps. Higher energy cyclotrons often have 3 or more dees.) The
engineering of the acceleration scheme for a cyclotron is simple compared to the initiation and
extraction aspects. The latter is made much easier by using H- rather than H+. H- ions are
accelerated through a thin carbon stipper foil, which strips the H- of its two electrons creating H+.
This change in charge causes the path to arc outwards and be directed towards an external target
for isotope production at an efficiency of nearly 100%. H+ ions are deflected by use of an
electrostatic channel that steers the ions out of the cyclotron often with an efficiency less than
75%. The beam that is lost using H+ deflection causes nuclear reactions making the internal
cyclotron parts radioactive.11,32

Figure 1-12. Schematic of a cyclotron5
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Nuclear Reactions (p,n) and (p,α)
Several proton induced nuclear reactions are attainable at low energies (11-30 MeV).
During most low-energy nuclear reactions the proton combines with the target nucleus to create a
compound nucleus. This compound nucleus is highly excited and deexcites by evaporating
particles, usually neutrons but sometimes protons or alpha particles and even more rarely larger
nuclei, and leaves behind a new isotope. For example a 15MeV proton combines with a 58Ni
atom forming a compound nucleus of 59Cu that then evaporates an alpha particle to become 55Co
(Figure 1-13). As in decay, the mass difference between reactants and products is the Q-value,
but it can be of either sign for reactions. The Q-value is most conveniently calculated by
subtracting the mass excess, Δ = (Actual mass in atomic mass units – A)*c2, of the products
from the reactants (Equation 7). (Mass excesses can be used as neither neutrons nor protons are
being created, they are just being rearranged – this is no different than a reaction enthalpy where
the masses of the atoms do not need to be considered as they just redistributed). The Q-value for
the reaction above creating 55Co is -1.33 MeV. This sign means that the mass of the products is
more than that of the reactants thus there is an absolute minimum proton energy below which the
reaction probability is zero.

Figure 1-13. Illustration of the nuclear reaction 58Ni(p,α)55Co.
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p+A

α+B

or

A(p,α)B

with

Q = Δ p + ΔA - Δα – ΔB

(7)

Another important factor to consider in reactions between charged particles is the
Coloumb barrier. Because the proton and the target atom are both positively charged, the proton
must overcome the Coulomb barrier (VC) approximately given by Equation 8 where Z1 is the
atomic number of the incoming atom (1 for proton initiated reactions), Z2 is the atomic number
of the target nucleus, and R1 and R2 are the radii of the incoming and target nuclei respectively.
In Equation 8, VC is in MeV when R is in fm.10,11 The larger the Coulomb barrier, the more
energy must be provided for the reaction to occur with significant probability. The energy
required to overcome the Coulomb barrier for 58Ni(p,α)55Co is 5.52 MeV. The threshold energy
of the reaction (the amount of energy required for the reaction to occur) is the higher of the two
energies: the negative of the Q-value (a thermodynamic threshold) and the Coulomb barrier (a
kinetic threshold).
VC =

𝟏.𝟒𝟒∗𝒁𝟏 ∗𝒁𝟐

(8)

𝑹𝟏 +𝑹𝟐

The probability of a nuclear reaction occuring is called a cross section, a quantity with the
dimensions of area. Typically the units are given in millibarns where 1 millibarn = 1 x 10-27cm2.
Plotting the cross section vs incident particle energy yields an excitation function (Figure 1-14).
This functional dependence along with the thickness of the target can be used to estimate the
yield of a reaction (Equation 9) where R is rate per second, N is the number of target atoms per
cm2, σ is the cross section in cm2, and ϕ is the particle flux, which in this case is the number of
protons per second. If the target is sufficiently thick so that the energy of the projectile drops as
it proceeds though the target, the yield can be estimated summing (or integrating) the rate over
an imagined stack of (L) thin targets each with Ni atoms per unit area and a cross section σi
appropriate to the energy of the projectile when it arrives at that target slice. For bombardments
19

that are long compared to the half-life of the isotope being produced, saturation is achieved
resulting from the decay rate of the produced radioactivity rising to match the production rate. In
the work presented here I will discuss the use of small medical cyclotrons to produce 55Co via
the 58Ni(p,α)55Co reaction.
R = Nσϕ = ∑𝑳𝒊=𝟏(𝑵𝒊 𝝈𝒊 𝝓)

(9)

Figure 1-14. Excitation functions for the 58Ni(p,α)55Co reaction.4

This thesis will discuss the first attempts and “proof of concept” experiments for isotope
harvesting. In Chapter 2 a measurement will be presented that was useful for the development of
separation strategies for the harvesting of 67Cu and to measure the final purity of 55Co
productions. Chapter 3 will address the design of an end station for use at the end of a beam line
at the NSCL to collect isotopes in water. This end station was tested and validated using a
purified 24Na beam. Chapter 4 presents the collection of a mostly pure 67Cu beam and its
subsequent separation and use for antibody labelling. Chapter 5 expands on Chapter 4 by testing
the separation strategy using a no wedge beam (this means that the beam was not subjected to the
majority of the magnetic separation in the A1900) thus it contained many contaminants. This
20

chapter also presents the separation, purification and the radiolabelling of an antibody with 67Cu
followed by injection into tumor-bearing mice, and the resulting 5-day biodistribution. Chapter
6 consists of a side project, the production of 55Co via the 58Ni(p,α)55Co reaction, looking at free
55

CoCl2 (not chelated) in tumor bearing mice and the resulting biodistribution at 24 and 48 hrs,

along with labeling DOTA or NOTA conjugated peptides in order to determine the stability of
55

Co in DOTA and NOTA complexes in vivo. Conclusions and thoughts on future work are

presented in Chapter 7.
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Chapter 2
Specific Activity Measurement of 64Cu:
A Comparison of Methods
[This work has been published previously as Tara Mastren, James Guthrie, Paul Eisenbeis, Tom
Voller, Efrem Mebrahtu, J. David Robertson, and Suzanne E. Lapi, Applied Radiation and
Isotopes. 2014, 90, 117-121]
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Introduction
Specific activity is a measurement of the purity of a radioisotope. Effective specific
activity (ESA) is the amount of radioactivity per unit mass of competing metal for a certain
chemical or biological reaction. True specific activity is the amount of radioactivity per μmol of
atoms of the same element (for example amount of 64Cu per μmol total copper). Theoretical
maximum specific activity is the amount of radioactivity per μmol of the radioactive species (for
example radioactivity of 64Cu per μmol 64Cu). The theoretical maximum specific activity for
Cu, a common radiometal used in preclinical and clinical research, is 2.47 x 105 mCi/μmol.

64

The specific activity of a given radionuclide is important in developing the chemistry for
labelling compounds. Typically it is desired to have as close to the theoretical maximum specific
activity as is reasonably achievable. In radiometal productions many efforts are in place to
reduce the amount of contaminating metals present. Trace metal grade chemicals are used in
various cleaning and manufacturing steps and all glassware and materials that come into contact
with the radioactivity are washed in a nitric bath for 24 hours to remove surface metal
contaminants. Additionally, separation chemistries to isolate the radiometal of interest from the
target material are optimized to improve the final purity.
There is a growing demand for 64Cu for use in Positron Emission Tomography (PET)
research. A review of the literature shows that the number of publications involving 64Cu has
more than tripled since 2000. The 12.7 hr half-life and the low beta energy of 64Cu (Eavg = 0.278
MeV) makes it an optimal PET isotope for imaging up to 48 hours after administration (Figure
2-1). Similarly these properties of 64Cu make it an ideal candidate for labeling peptides and
antibodies as the time required for these tracers to accumulate in the target organs (a few to
several hours) requires labels with commensurate half-lives.1-7
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Figure 2-1. The decay scheme for 64Cu showing decay by β+, β-, and ε.

Measurement of the effective specific activity (ESA) of 64Cu is important to the
application of 64Cu because metal impurities present in the sample can have a negative impact on
radiolabelling.8 The current and most common method for measuring the effective specific
activity (ESA) of 64Cu productions is by titration with a suitable chelator such as 1,4,8,11tetraazacyclotetradecane-1,4,8,11-tetraacetic acid (TETA).9,10 This approach measures the ESA
relative to the metal’s affinity for the TETA molecule but does not distinguish between the
different types of metals present in the sample. Other methods that have been developed to
measure ESA of 64Cu include voltammetry, liquid chromatography-mass spectrometry (LC-MS),
and inductively coupled plasma mass spectrometry (ICP-MS). Voltammetry measures the
amount of cold (non-radioactive) copper contamination but not the amount of the other
contaminating metals.11 The recently reported LC-MS method measures the concentration of
metal contaminants present that bind to a particular chelator, however it is a relatively expensive
and complex method that may also require additional method development for new chelators.8
While ICP-MS is a sensitive multi-element analysis technique that can simultaneously determine
the concentration of all the metal contaminants in the sample, it is also an expensive technique
and not readily available at all institutions for radioactive samples. For this reason, a method is
28

desired that is robust and will identify and measure trace amounts of metal impurities in samples
of 64Cu.
In this chapter a high-performance liquid-chromatography (HPLC) ion-chromatography
method that measures trace amounts of metals (ppb) was used to measure the transition metal
contaminants in twenty different 64Cu lots produced at Washington University School of
Medicine. This method was validated by comparing the data to the current TETA titration
method and ICP-MS. Ion chromatography is simple, fast (<25min), and practical for routine
measurement of the cold metal contaminants in a radioactive sample of 64Cu. Due to the high
sensitivity of this technique, ion chromatography was instrumental in determining separation
strategies for isotope harvesting experiments where radioactive tracers could not be employed.

Materials and Methods
TETA Titrations: Trace metal grade reagents including ammonium acetate, ammonium
hydroxide, and hydrochloric acid were obtained from Sigma Aldrich (St. Louis, MO). 1,4,8,11tetraazacyclotetradecane-1,4,8,11-tetraacetic acid was obtained from Macrocyclics (Dallas,TX).
64

Cu was produced in house at Washington University using an automated module.12 2 mL

microcentrifuge tubes were acid washed in 50% nitric acid bath overnight before use. TLC
plates (silica gel 60F-254 glass 5x10cm 0.25mm precoat) were obtained from Millipore
(Billerica, MA).
Ion Chromatography: PDCA (1.4 mM pyridine-2,6-dicarboxylate / 13.2 mM
Potassium hydroxide / 1.12 mM Potassium sulfate / 14.8 mM Formic acid) PAR (4-(2pyridylazo)resorcinol), and PAR dilutent (1.0 M 2-dimethylaminoethanol/0.50 M Ammonium
hydroxide/0.30 M Sodium bicarbonate) were obtained from Dionex. TraceSELECT Ultra, ACS
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reagent for ultratrace analysis water and nickel, copper, cobalt, iron, and zinc and TraceCERT
atomic absorption standards 1000 mg/L were obtained from Sigma (St Louis, MO).
Mass Spectrometry: A PerkinElmer NexION 300X ICP-MS was used for all ICP-MS
measurements. Linearity standards were prepared from commercial multi-element and singleelement solutions (High Purity Standards). The diluent for samples and standards was a solution
of 3% w/w HNO3 that was prepared from Optima grade nitric acid (Fisher Scientific) and fresh
18.2 MΩ-cm water (EMD Millipore)

TETA Titration
The TETA titration method was based on that reported previously.8 7.4 MBq (20 µL) of
64

Cu was added to eight different concentrations of TETA in ammonium acetate pH 5.5 ranging

from 4.3 × 10-4 nmol to 6.3 × 10-1 nmol. Final volume was brought to 100 µL using 0.5 M
ammonium acetate buffer pH 5.5. The solutions were placed in an agitating incubator at 80 ºC
for 20 min. Solutions were cooled to room temperature and then centrifuged. A 1µL sample
from each TETA concentration along with 1 µL unbound 64Cu was analyzed for percent 64Cu
incorporation determined by Thin Layer Chromatography (TLC) using silica plates and 1:1
mixture of 10% ammonium acetate and methanol as an eluent. Plates were analyzed using a
Radio TLC Plate Reader (Bioscan, Washington DC). Data was plotted as molar concentration of
TETA vs. % 64Cu incorporation. The curve was fit using a sigmoid plot fit program in Prism
(Graphpad, California). The EC50 value, concentration of TETA that bound to 50% of the 64Cu,
was determined from this fit. The ESA was set equal to two times the EC50 value.
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Ion Chromatography
Twenty completely decayed 64Cu lots of varying activity at end of bombardment were
measured at two concentrations in triplicate. Each sample was originally brought to 1mL by
adding TraceSELECT Ultra water (Sigma), then samples were diluted to 74 kBq/µL (back
calculated activity to end of bombardment for the sample) with TraceSELECT Ultra water 0.740
kBq and 18.5 MBq from this dilution were brought to a final volume of 3 mL with
TraceSELECT Ultra water. The concentrations were adjusted depending on the amount of metal
contamination present. The lower concentration was typically used to measure contaminating
nickel at 1-10 µg/L and the higher concentration solution was used to measure the copper, iron
and zinc contaminants at 1-10µg/L. A metal-free HPLC system equipped with a GP-50 pump,
AD20 detector, and a PC10 post column delivery system was used with a Dionex CS5A 2-mm
Transition Metal Column. 1mL of each sample was injected into the metal free ion
chromatography system. The eluent (1.4 mM pyridine-2,6-dicarboxylate / 13.2 mM Potassium
hydroxide / 1.12 mM Potassium sulfate / 14.8 mM Formic acid) was passed through the column
at 0.30 mL/min. As the metals elute from the column they pass through a mixing loop with 1.0
M 2-dimethylaminoethanol/0.50 M Ammonium hydroxide/0.30 M Sodium bicarbonate
containing 0.06g/L 4-(2-pyridylazo) resorcinol (PAR) at 0.15 mL/min. This post column reagent
flow is controlled by the PC-10 post column delivery system using pressurized helium. During
this time the metals complex with the PAR dye prior to UV analysis at 530 nm. Calibration
curves that ranged from 1 µg/L to 10 µg/L were made for copper, nickel, zinc, cobalt, and iron
using TraceCERT atomic absorption standards, 1000 mg/L in nitric acid.
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ICP Mass Spectrometry
Linearity standards were prepared in 3% HNO3 from a commercial high purity standards
multielement solution containing all elements of interest. Individual single-element standards of
Zn and Ni were also prepared in order to measure and normalize for mass fractionation among
Ni isotopes. The internal standards Sc, Ga, and In were added to all samples and linearity
standards in order to compensate for matrix effects and instrument sensitivity drift.
Samples were analyzed using a PerkinElmer NexION 300X ICP-MS operated in KED
(Kinetic Energy Discrimination) mode. All isotopes were analyzed twice, once at a helium flow
of 2.5 mL/min (low flow) and 4.5 mL/min (high flow). High-flow results are reported all
elements measured.

Results
TETA Titrations
ESA as measured by TETA titration over the twenty lots varied between 49.6 and 973.1
GBq/µmol.

Ion Chromatography
Calibration curves for five different metals including iron, copper, nickel, zinc, and cobalt
were linear at concentrations ranging from 1µg/L to 10µg/L with R2 values of 0.95 or greater
(Figure 2-2). Standard error of the estimate for the five curves were calculated to be 2.01 µg/L
for iron, 0.56 µg/L for copper, 0.48µg/L for nickel, 0.42µg/L for zinc, and 0.05µg/L for cobalt.
The lower limit of detection was 1µg/L for copper and cobalt, 2µg/L for nickel and iron, and
3µg/L for zinc. Figure 2-3 shows an overlay of the 5µg/L calibration sample with a blank. The
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absorbance of the five different metal-PAR complexes at 530 nm are different when measuring
the same concentration. This can be seen in Figure 2-3 and is responsible for the different
slopes shown in Figure 2-2.
Ion chromatography yielded the concentration (mg/L) of cold copper, nickel, zinc, and
iron that were present in the 64Cu samples diluted to 1mL, cobalt was not detected as a
contaminant. Figure 2-4 shows the amount in mg/L of nickel, copper, iron, and zinc measured
by IC compared to ICP-MS of each of the twenty samples measured with the exception of zinc
which only shows IC measurement.

Figure 2-2. Calibration curves for assessment of metal contamination using ion
chromatography. Five calibration curves were made for iron, copper, nickel, zinc, and cobalt.
R2 values for these curves were > 0.95. The lower limit of detection that resulted in a linear
curve for copper and cobalt is 1 ug/L, iron and nickel is 2 ug/L, and zinc is 3 ug/L. All
samples were brought between the lower limits and 10 ug/L for analysis.

33

Figure 2-3. Ion Chromatography of the 5µg/L calibration standard. From left to right peaks
represent iron, copper, nickel, zinc, and cobalt. The absorbance at 530nm was measured.

Figure 2-4. Ion Chromatography vs ICP-MS. The amount in mg/L of nickel, copper, iron,
and zinc measured by IC compared to ICP-MS of each of the twenty samples measured with
the exception of zinc which only shows IC measurement.
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When constructing the calibration curves zinc contamination was an issue. All glassware
and vials must be acid washed for at least 24 hrs in 50% HNO3 to minimize contamination. Zinc
was a perpetual contaminant in the autosampler vials so manual injections using 5.0 mL syringes
(Thermo Scientific SUN-SRi™ Luer-Slip Syringes) were used and found to be free of zinc
contamination. Additionally TraceSELECT Ultra water (Sigma, St Louis) had to be used for all
dilutions as the in-house milli-Q water contained as much as 3 ppb zinc. Storage of the sample
in 2.0 mL acid washed microfuge tubes for a significant amount of time (weeks or more) will
lead to zinc leaching out from the plastic, therefore it was best to make all dilutions immediately
prior to analysis in order to minimize this contamination.

Mass Spectrometry
ICP-Mass Spectrometry was used as the “gold standard” method to validate ion
chromatography for determining amounts of metal impurities. The Bland-Altman method13 was
used to compare the ion chromatography measurements with those from ICP- Mass
Spectrometry and the results are graphically shown in Figure 2-5. Iron had a bias of -33.2μg/L
with a 95% confidence interval of -126μg/L to 60.2μg/L and copper, with the exception of lot #8
which was omitted due to high variation, had a bias of -11.1μg/L with a 95% confidence window
of -78.7μg/L to 56.6μg/L. Nickel was separated into two calculations, for lots under 20mg/L the
bias was -0.241mg/L and had a 95% confidence window from -1.11mg/L to 0.602mg/L and at all
concentrations ranging up to 50mg/L the bias was -0.755mg/L with a 95% confidence window of
-4.1mg/L to 2.6mg/L.
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Figure 2-5. Bland-Altman plots comparing ion chromatography to ICP-mass spectrometry.
Iron (squares), copper (circles), and nickel (triangles) < 20mg/mL top left all concentrations
top right.

The difference in zinc measurements was quite large and it is likely that the samples were
contaminated with zinc between the two measurements, likely caused by zinc leaching from the
plastic microfuge tubes used to transport the samples to the ICP-MS lab, and therefore the results
are not shown. ICP-MS did show very small concentrations of cobalt (0.34-12 μg/L) which was
much lower than the detection limit of the Ion Chromatography method and considered
negligible compared to the other metal contaminations.
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Discussion
TETA titration, ion chromatography, and ICP mass spectrometry data were compared in
order to analyze large variances in ESA. TETA values in seventeen lots were graphed against
true specific activity (64Cu radioactivity per µmol copper) in Figure 2-6, two lots were left out
due to variation from the trend likely a result of TETA titration error. A link between cold copper
contamination and effective specific activity is observed which was expected. The ESA values
were lower than the true specific activity values. This difference is likely due to the contribution
of other metals such as nickel and iron binding to the TETA molecule thus affecting the
measurement. The log K values for copper, nickel, and iron for TETA are 21.7, 19.91, and 13.1
respectively and the moles of TETA remaining compared to the moles of nickel and iron
available for binding are quite small and thus both are believed to have some effect on overall
specific activity.

Figure 2-6. Effective vs True Specific Activity. The graph of effective specific
activity (TETA) vs. true specific activity (ICP-MS) illustrates the relationship
between copper contamination and TETA specific activity.
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Sources of copper contamination are currently being explored. One potential source is
the raw 64Ni material. Other potential sources are the reagents used in the purification chemistry
or contamination during the electroplating process.
For routine analysis the TETA and ion chromatography method are useful in determining
impurities and ESA of different lots of 64Cu. Ion chromatography is useful as a troubleshooting
method as it can show which metals are contaminating a sample and help to determine the source
of the contamination. ICP mass spectrometry is useful for looking at all the impurities that could
be present and also to confirm routine measurements.

Conclusions
Ion chromatography is a good method for routinely analyzing trace amounts of transition
metals in radioactive samples. This method can measure in the parts per billion range and
therefore large amounts of radioactivity do not have to be injected in order to get an accurate
measurement. The main drawback for measuring metal contaminants in 64Cu productions is
determining the dilution factor that brings the low levels of copper and iron to the 1-10 µg/L
range required for detection. More work will be done to determine the source of the cold metal
contaminants, steps that can be done to minimize or eliminate them, and at what concentration
these impurities have the largest effect.
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Chapter 3
Design and construction of a water target system for harvesting
radioisotopes at the National Superconducting Cyclotron
Laboratory

[This work has been published previously as Aranh Pen, Tara Mastren, Graham F. Peaslee, Kelly
Petrasky, Paul A. DeYoung, David J. Morrissey, Suzanne E. Lapi, Nucl Instrum Meth A. 2014,
747, 62-68]

41

Introduction
FRIB is currently scheduled for completion in 2022 and will have the capacity to
accelerate uranium up to energies of 200 MeV/nucleon, and lighter ions to slightly higher
energies, with a beam power as high as 400 kW to produce a broad range of rare radioisotopes
through fragmentation. FRIB will provide these high-power beams at intensities several orders
of magnitude higher than are currently obtainable, which will provide the most intense secondary
ion beams of these rare isotopes in the world.1 The unused radioisotopes will be stopped in the
cooling water in FRIB’s primary beam dump, a spinning titanium container with cooling water
circulating at ~300 gallons per minute to dissipate the large heat load and provide a vehicle for
the storage and disposal of unused radioisotopes. The technology to pass large volumes of
cooling water through ion-exchange columns to remove radioisotopes has been well-developed
in the nuclear power industry,2 and the ability to conduct radiochemical separation and
harvesting of certain long-lived radioisotopes from the cooling water of the primary beam dump
has been designed into FRIB.3 Developing aqueous extraction and separation methods for the
ancillary harvesting of specific radioisotopes from FRIB’s beam dump would be beneficial to
many isotope users without interfering with the primary users’ experiments.
Radioisotope harvesting of 13N has been conducted in the past from the interaction of a
fast 14N primary beam with water,4 but harvesting experiments with heavier beams had not been
conducted before this work. In the study just cited only a few radioactive products could be
produced in the water and 13N was found to be the predominant activity. Experiments were
needed, where collection of the secondary beam and fragmentation products is achieved, in order
to determine the viability of “harvesting” isotopes of interest from an aqueous beam stop.
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In order to collect the secondary beam an end station was designed that could stop the
ions in an aqueous target. In this chapter this end-station design and construction is discussed in
detail and results of testing using an analyzed high-energy beam of 24Na are presented. The 24Na
collected in the water was isolated in order to obtain an extraction efficiency. Using this end
station, the efficiency with which this isotope, and other isotopes of interest, would be extracted
from water could be measured, optimized and compared to the direct measurement of the
production rate in the A1900 separator (see below). This efficiency could then be used to
estimate the activity of isotopes of interest that would potentially be extracted from the FRIB
beam dump.5,6 The development of a water-based target system for harvesting radioisotopes at
the NSCL was the initial step for the proof-of-principle experiments to harvest useful
radioisotopes from FRIB.

Materials and Methods
End Station Design
In order to collect and isolate specific radioisotopes of interest from a cocktail of other
isotopes produced at the NSCL, a complete, remote-controlled, water target system was
designed, constructed and tested with a radioactive beam. The following features were included
in the final system:
The system had to be completely automated, remote-controlled and operated from outside
the experimental vault during beam irradiation for radiation safety reasons.
This system had to be capable of performing several remote water collection/storage
cycles before being recharged in order to conduct systematic studies with various beam
conditions (six in the present case). For example, the purity or intensity of the analyzed beam

43

could be changed and deposited into separate water volumes. Thus, a water manifold system to
move volumes of water to/from the target cell into separate collection vessels was necessary.
During the previous light-ion extraction experiments,4 radiolytic production of
radioactive gases was observed, thus the target water cell was designed to include a gas manifold
system to capture off-gases and to purge the target water with helium to remove dissolved gases
before irradiation. In addition, the target system was designed to be physically isolated from the
accelerator vacuum system by passing the high-energy beam through an air gap before reaching
the water target.
These features were realized in a stand-alone unit with a main enclosure housing the
hardware and plumbing and a second enclosure housing the electronics, all controlled remotely
over ethernet. There are three main components to the stand-alone unit: first, a water-holding
reservoir in which aliquots of purified water were held in individual commercially-available
HDPE (high density polyethylene) containers. There are six 175 mL conical HDPE bottles
(Nalgene, 3143-0175) in the water reservoir system, each filled with 100 mL of distilled water
(Sigma-Aldrich, 7732-18-5) prior to beam collection. The water in each reservoir was sparged
with helium for ~30 minutes prior to irradiation. A flow sensor (Omron Electronics Inc – EMC
Div, D6F-P001A1) was used to ensure that the helium, regulated by an electronic valve (SMC,
ITV1010-21N1BS4), was properly flowing during sparging and when pushing the water though
the manifold system to/from the target cell. A pressure sensor (Honeywell Sensing and Control,
SSCSANN001BGAA5) was used to monitor the irradiation cell for gases produced during beam
collection. Second, a custom irradiation cell was built, into which water was transferred from the
holding reservoir, for stopping and collection of the beam particles. The target cell had a thin
entrance window (8 µm Kapton) and was constructed from PTFE (polytetrafluoroethylene). The
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internal volume of the irradiation cell took the shape of a truncated cone for containing any
divergence of the stopping secondary beam, see Figure 3-1. Third, a movable carousel of
commercially available PTFE bottles was included for the transfer and temporary storage of the
irradiated water samples. After irradiation, the water was transferred to a collection bottle via a
tube supported on a pneumatic linear actuator (SMC, CDJ2KB16-45-B) that extended into the
bottle to capture any spraying during liquid transfer operations. The actuator was retracted before
movement of the carousel to the next collection bottle. Two magnetic sensors (Cherry,
MP201802) on the linear actuator were used to confirm that the actuator rod was in the up
position before rotating the carousel or that it was the down position and the tubing was in the
bottle, ready for dispensing water from the target cell. There were ten PTFE collection/storage
bottles (Cole-Palmer, 015.150.2) in the 35.6 cm diameter carousel for post-irradiation retrieval of
the water. A stepper motor (Lin Engineering, 85BYGH450A-08), controlled by a stepper motor
drive (Lin Engineering, CW250), was used to rotate the carousel and position the collection
bottles as necessary. Four photo sensors (Sharp, GP1A57HRJ00F) viewed notches cut into the
carousel plate to identify each of the ten bottle positions. A fifth photo sensor was used to center
each bottle prior to reading the position identification and a capacitive sensor (Carlo Gavazzi,
CD50CNF06NO) was used to determine if the collection bottle contained water thus ensuring
that a new sample would not be delivered to a filled bottle. All components of the system that
could come into contact with water were metal-free (or Teflon-coated) to reduce metal
contamination and the loss of aqueous radioisotopes by plating onto metal surfaces. The end
station incorporated metal-free, air-operated, normally closed, two-way valves (SMC, LVQ20Z07N) controlled by low-voltage (5V) solenoids (SMC, SY3A00-5U1, manifold: SS5Y3-10F212BS-N7D0). FEP (Fluoroethylpropylene) fittings (SMC, LQ3 Series) and Teflon tubing (SMC,
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TIHA07N-33) were used if they came in contact with water. A Measurement Computing I/O
device (Measurement Computing, USB-1208LS, USB-SSR24, SSR-ODC-05) was used to
communicate with the sensors and to control the stepper motor and electronic valve regulators
(for both the helium used for sparging the water and the air for operating the metal-free valves.
The entire end station was remotely operated using LabVIEW software (National Instruments,
776670-35).

100 mL

Secondary beam
24Na

Figure 3-1. Schematic design of the PTFE water target cell containing 100 mL of water.
Dimensions are in inches [mm], angles in degrees.

46

A concern during operation was the possible over-pressurization of the irradiation cell
due to localized heat production and radiolysis of water, producing radioactive and other gases.
This concern was addressed by programming the LabVIEW system to open the helium exit valve
on the top of the cell and venting the cell into a 152 m (500 ft) length of 6.35 mm (¼ inch) tubing
if the target cell pressure exceeded 0.14 atm above gauge (2 psig) as determined by the pressure
sensor installed to monitor the irradiation cell. This length of tubing was calculated to exceed
the distance traversed by the diffusion of 11CO2 at atmospheric pressure through the tube within
10 half-lives of 11C.
In addition to the safety checks built into the LabVIEW control program, two webcams
and LED lighting strips were added to allow visual monitoring of the end-station. Remote
desktop connections were used to control the LabVIEW programs running in two laptop
computers physically wired to the end-station electronics in the vault. A radiation monitoring
system was also incorporated into the end-station to qualitatively measure the presence of
activity in the proper locations. The radiation detector system consisted of eight CsF detectors
each with a photomultiplier tube, a fast discriminator and a scaler. These detectors were placed
at different locations within and outside the target assembly to monitor the flow of radioactive
solutions into different collection vessels during the experiments to ensure the radioactivity was
moving only to the desired location. A schematic diagram of end station is shown in Figure 3-2,
and photos of the completed system are shown in Figure 3-3. The end-station was fabricated at
Hope College and then installed in the S1 vault at the NSCL.
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Water reservoir

PTFE water target
irradiation cell

Metal-free valves

Flow sensor

Carousel
Linear actuator
with magnetic
sensors

Electronics box

Collection/storage
PTFE bottles

Figure 3-2. Schematic diagram of the complete end-station. The doors to the end-station are
shown in the open position, and the reservoirs at the top and the carousel at the bottom are
apparent. The electronics control box is in the background at floor level.
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Figure 3-3. Photographs of the water cell collection end-station. (Left) Installation in the vault
where the beam enters from the left, A is the side of the isolation box that holds the target cell
and associated plumbing (see Fig. 3-2). B houses the electronic controls and C is a laptop that
controls the system. (Center) Side view of the target end-station that shows D: the water
reservoir system, E: the PTFE target cell and F: the rotating collection bottle system, (Right)
Close up of the end of the beam line and G: water cell window, H: a removable scintillator in
front of the target assembly, I: beam collimator.

Simulation Results
As part of the planning process, modeling of the radioisotopes delivered to the water cell
by the A1900 and their decay products was carried out using the LISE++ code5 with the EPAX3
cross sections6 and the Nucleonica© decay engine,7 respectively. The information from these
programs was only used to estimate the amount of radioactivity in the solutions collected and to
identify potential contaminants in the secondary beam prior to the measurements. These first
tests of the production and collection focused on 24Na because of its convenient 14.997-hour
half-life and its characteristic high-energy gamma-ray emission which allowed identification and
quantization by offline gamma-ray spectroscopy. It was decided to produce the 24Na from a 40Ar
primary beam based on the high availability of the argon beam and the relatively efficient
delivery of 24Na by the separator. Calculations using the LISE++ code indicated that significant
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amounts of other radioisotopes would not be present in the analyzed 24Na beam, therefore neither
extraction nor separation was necessary post irradiation, allowing the focus to remain on
determining the overall collection efficiency.
The LISE++ calculation (version 9.4.15) for an 40Ar primary beam (140 MeV/u) at the
maximum intensity available at the NSCL of 75 pnA,8 using an 1151 mg/cm2 thick beryllium
production target and a 289 mg/cm2 aluminum wedge with a 1 percent momentum acceptance at
the Image-2 position9 predicted a 70% pure beam at the collection station that would result in
~1.7 ×1010 24Na particles at (~88 MeV/u at the A1900 focal plane) 85 MeV/u after the water
target window after the minimum collection time of one hour (see below). Table 3-1 provides a
list of the isotopes in the separated secondary beam that have a production rate greater than 1 s-1
(note that the predicted production rate of 24Na under these conditions is 4.62×106 s-1). The next
most abundant isotope was stable 25Mg at 28% of the total rate while the remaining 2% consisted
of a few nuclides that do not contribute to the radioactivity levels after a five minute cooling
period. If all the kinetic energy of the incident secondary beam was absorbed in the water there
would be a negligible temperature increase of <0.05 K in the 100 mL of water in the irradiation
cell. This value was calculated for the total collection time, the production rate and kinetic
energy of each nuclide. Table 3-1 shows that the only significant activity delivered to the water
was 24Na,
Table 3-1. Predicted production rates of isotopes greater than 1s-1
Nuclide
26

Al
Mg
24
Na
23
Ne
21
F
20
O
17
C
Total
25

Half-life

Focal Plane Rate (s-1)

717 ky
Stable
14.997 h
37.2 s
4.16s
13.51 s
193 ms
6.60E+06

8.97E+01
1.84E+06
4.62E+06
1.37E+05
5.63E+01
4.30E +03
2.43E+01

50

Activity
(Bq, 5m EOB)
~0
0
2.1E+05
90. ~ ~0
0
~0
0

however, the fast beam will react with the hydrogen and oxygen nuclei in the water to produce
some 18F, 15O and 11C. This production is more difficult to model so the samples were held for
about 8-24 hours prior to shipping to allow these intermediate half-life isotopes to decay.

24Na

Beam Collection
The water target system was used to collect four separate samples during a 24 hour

period. As in the simulations described above, the 40Ar18+ primary beam at 140 MeV/u was
fragmented in a beryllium target to produce 24Na. The 24Na ions were separated in the A1900
projectile fragment separator9 and arrived at the focal plane with an energy of ~88 MeV/u. The
primary beam intensity was attenuated by a factor of ~10 for the first two sample collections,
then delivered at the full intensity of ~75 pnA for two additional sample collections. The exact
experimental parameters are listed in Table 3-2. The primary beam was incident on an 1151
mg/cm2 beryllium target, the A1900 separator was set for maximum production of the 24Na
fragment with momentum acceptance slits adjusted to a 1% momentum full acceptance using a
289 mg/cm2 aluminum wedge in the center of the A1900 separator, and the focal plane (FP)
mass-selection aperture was 10 mm. The beam intensity and purity were measured using the
common delta-E/Time-of-Flight technique with the standard A1900 focal plane silicon-PIN
diode and cyclotron RF signal prior to delivery of the beam to the experimental end station. The
24

Na production rate at the focal plane was ~1.04(0.02)x105 pps 24Na per pnA of primary beam

and the exact composition of the secondary beam during the sample collections, i.e., 72(2)%
24

Na was in good agreement with the simulation. In addition, the “FP plastic scintillator” made

of 150 m BC-400 (CRAD06) was positioned in the path of the beam for beam normalization
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(calibration) runs and removed when collecting the 24Na secondary beam in the water. The
scintillator was used to directly measure the beam intensities at rates below ~106 pps. During the
sample collection runs the beam exited the vacuum system through a 75 µm zirconium exit
window, followed by a 89 mm air gap, entered the water cell through a 8 µm Kapton window,
and had a calculated range of ~11 mm in the distilled and degassed H2O (73 mm thick). The
primary and secondary beam intensities were recorded by various intercepting and
Table 3-2. A1900 fragment separator and beam line settings for 24Na production.
Block

Description

Value

Primary Beam Target

Beryllium

D1 Bρ

Dipole Magnet

3.16650 Tm

D2 Bρ

Dipole Magnet

3.16650 Tm

I2 Slits

1% Momentum Acceptance (dp/p)

I2 Wedge

Aluminum

D3 Bρ

Dipole Magnet

3.01230 Tm

D4 Bρ

Dipole Magnet

3.01230 Tm

CRAD06

BC-400 Scintillator (removable)

D5 Bρ

Dipole Steering Magnet

3.01230 Tm

D6 Bρ

Dipole Steering Magnet

3.01230 Tm

Exit Window

Zirconium

Air Gap

Air

88.9 mm

Collimator

Aluminum, 3.175 cm diameter

6.35 mm

CRAD02

BC-400 Scintillator (removable)

150 µm

Water Target Window

Kapton

Water Target

Liquid water

1151 mg/cm2

60 mm
289 mg/cm2

150 µm

75 µm

8 µm
73 mm
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non-intercepting detectors during different phases of the experiment (Figure 3-4). A 6.35mm
thick aluminum collimator was placed in front of the exit window scintillator (at the end-station)
to ensure only the particles that entered the water cell were counted.

S1 Vault

CRAD-02
Scintillator

Water Target
End-station

CRAD-06
Scintillator
Z013L-C
Z001I-C
Z001F-C

Figure 3-4. Schematic diagram of NSCL indicating approximate locations of intercepting and
non-intercepting detectors (Z001I-C, Z001F-C, Z013L-C, CRAD-06 and CRAD-02).

The FP scintillator could only be used to monitor the secondary beam at lower intensities
(with saturation occurring around 106 pps). In order to collect the maximum amount of 24Na and
not be limited by the scintillator, a non-intercepting beam monitor was necessary that: 1) could
measure high-intensity primary beam directly or indirectly, 2) could continuously monitor the
beam, and 3) had a linear relationship to the counting rates observed in the scintillators at lower
beam intensities. The secondary beam rate was indirectly determined using two different
methods. In the first method the 24Na rate at the end station was calculated from the FP
scintillator by constructing a calibration curve obtained from measurements of the beam at
various intensities using a series of Faraday cups that intercept the primary beam, the Z001I-C
and Z013L-C non-intercepting primary beam monitors, and the FP scintillator in the secondary
beam path. The Z001I-C is a non-intercepting beam monitor just before the A1900 production
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target that provides a signal proportional to the primary beam intensity. The Z013L-C nonintercepting beam monitor in the first dipole of the A1900 also provides a signal proportional to
the primary beam intensity. During the sample collection runs, when the scintillator was
removed from the beam, data from the Z001I-C and Z013L-C non-intercepting beam monitors
were used to determine the secondary beam intensity. The calibration curve obtained for the
Z013L-C beam monitor is shown in Figure 3-5. The second method relied on using the 24Na
production rate measured at the A1900 focal plane prior to the collection runs, as indicated
above, combined with an estimate of the primary beam intensity. The data from non-intercepting
Z001I-C beam monitor was used to infer the primary beam current during the run using a
calibration established with a Faraday cup that intercepted the primary beam at the A1900 target
position (Z001F-C).

2.0E-07

Z001F-C (A)

1.5E-07

y = 3.7151×10-04x - 2.6735×10-08
R² = 0.99871

1.0E-07
5.0E-08
0.0E+00
-5.0E-08
0.0E+00

2.0E-04
4.0E-04
Z001I-C (A)

6.0E-04

Figure 3-5. Calibration curve for the non-intercepting primary beam monitor Z001I-C
versus the intercepting Z00lF-C Faraday cup signal intensity.
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After the isotope collections were complete, the samples were transported approximately
one day later to Hope College for preparation and analysis. The 100 mL samples of water were
reduced to ~15 mL via gentle evaporation and quantitatively transferred to an x-ray fluorescence
(XRF) cup with minimal air gaps, which was then capped with an 8 µm Kapton window for
offline gamma spectrometry. Each sample was measured repeatedly for at least 20 minutes over
a 5-day period in a low-background radiometric detection facility at Hope College. The three
low-background systems at this facility consist of three Ortec 20% high-purity germanium
detectors with resolutions of 1.2, 2.5, and 4.1 keV at 1369 keV, shielded by layers of aluminum
(0.5”), copper (0.5”) and lead (4”). Gamma ray spectra were recorded and peak integrations and
background subtractions were performed using a linear function background fit to each peak for
the 1369 keV gamma ray of 24Na. Besides the 511 keV peak, there were no other radionuclides
greater than 0.5% of the 1369 keV peak detected in the samples. These detectors were calibrated
with known sources for energy calibration and absolute counting efficiency. The number of ions
implanted in the water were then calculated and used to determine the collection efficiency.

Experimental Results
The primary beam intensity was calculated using the Z001F-C vs Z001I-C calibration
curve (Figure 3-5) and the integrated data for Z001I-C obtained during each run. As the
relationship between Z001F-C and 24Na was 1.04(0.02)×105 24Na/pnA (where pnA is the
intensity of the 40Ar primary beam measured by the Z001F-C detector), obtained from the beam
analysis conducted by the A1900 group, the 24Na rate at the focal plane could be calculated.
Table 3-3 contains a summary of the numerical results obtained for the sample collection runs.
The gamma-ray spectroscopy of the samples yielded results having a precision of ~1%. This
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value is the relative experimental precision of multiple measurements of the same aliquot. The
calculated extraction efficiencies, taken as the ratio of the number of particles at the A1900 focal
plane and the number of particles observed in the water was 20 ± 1%. This modest collection
efficiency is believed to be due, in part, to beam losses between the focal plane and the endstation. The estimated losses during the handling of the aqueous 24Na solutions were less than
10%. Thus, we observed approximately 70% loss in beam transmission between the focal plane
and the target. The typical transmission from the A1900 to end-stations at the NSCL is
approximately 80 to 90% and thus the observed losses are surprisingly large. Since the goal of
the experiment was not to obtain maximum yield of the 24Na particles, but rather to demonstrate
isotope collection and subsequent harvesting, the beam line transmission was not optimized.
Table 3-3. Summary of the 24Na collection efficiencies.
24

Na particles
Run 1

Run 2

Run 3

Run 4

γ-spectroscopy

5.84E+08
± 4E+06

7.19E+08
± 5E+06

1.90E+10
± 1E+08

1.85E+10
± 1E+08

Focal Plane Particles Calculated
by FC (Z001I-C)

2.83E+09
± 9E+07

3.8E+09
± 1E+08

9.5E+10
± 3E+09

8.8E+10
± 3E+09

0.21 ± 0.01

0.19 ± 0.01

0.20 ± 0.01

0.21 ± 0.01

2.8E+09
± 1E+08

3.6E+09
± 1E+08

9.0E+10
± 4E+09

8.4E+10
± 3E+09

0.21 ± 0.01

0.20 ± 0.01

0.21 ± 0.01

0.22 ± 0.01

Extraction efficiency
Focal Plane Particles Calculated
by scintillator (CRAD06)
Extraction efficiency

Conclusions
A water filled collection system was constructed and has been successfully used to stop a
beam of ~85 MeV/u 24Na produced at the NSCL. The end station operated flawlessly during
irradiation and multiple samples were collected remotely at particle intensities of ~2x106 pps.
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The samples were transported and characterized off-line in a remote location by gamma
spectroscopy using HPGe detectors. Two independent methods of calculating the secondary
beam intensity agreed within ~1% providing confidence that the total beam intensity was wellknown. There were no observed release of radiolytic gases from the system nor any spills or loss
of radioactive liquids. This work compromises the first step in providing the viability of isotope
harvesting from heavy-ion beam facilities using a water activity accumulation cell.
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Chapter 4
Feasibility of Isotope Harvesting at a Projectile Fragmentation
Facility: 67Cu
[This work has been published previously as Tara Mastren, Aranh Pen, Graham F. Peaslee, Nick
Wozniak, Shaun Loveless, Scott Essenmacher, Lee G. Sobotka, David J. Morrissey, and Suzanne
E. Lapi, Scientific Reports. 2014]

60

Introduction
With the successful construction and validation of the end station discussed in chapter 2,
we are now ready to move onto one of the isotopes of interest listed in Table 1-2. The isotope
we chose to start with, which can be used in medicine as a therapeutic isotope, is 67Cu.2-4 Its
relatively long 2.58 day half-life is ideal for labeling antibodies that typically have several-day
biological half-lives and its maximum β- energy of 562 keV makes it a good candidate for
radiotherapy.
Obtaining therapeutic doses that are typically on the order of hundreds of mCi/patient5
has proved to be quite difficult due to inconsistent production and no reliable supply.5-8

67

Cu can

be made via several nuclear reactions: 68Zn(p,2p)67Cu, 70Zn(p,α)67Cu, 67Zn(n,p)67Cu, and
68

Zn(γ,p)67Cu; however each reaction has practical drawbacks. For example, 68Zn(p,2p)67Cu has

a small but broad (in energy) cross section (Figure 4-1) and in order to efficiently produce the

Figure 4-1.
section.1

68

Zn(p,2p)67Cu excitation function showing low but broad (in energy) cross

61

large quantities needed for therapeutic doses thick targets and high-energy proton accelerators,
such as those at Brookhaven9,10 or Los Alamos National Laboratories,11 need to be employed.
These facilities have missions that make routine production of 67Cu problematic.5 Studies at
several facilities of the 70Zn(p,α)67Cu reaction have obtained varying yields and the production of
the large quantities needed for therapeutic studies are challenging with this method.12-14
Production via the 67Zn(n,p)67Cu and 68Zn(γ,p)67Cu reactions have undesirable side reactions and
concerns about waste products create challenges for their large scale use.5 It is estimated that
FRIB will be able to produce a saturated activity of 67Cu as high as ~2 Ci depending on the
primary beam15 so that harvesting of 67Cu could provide a consistent supply of this isotope.
Figure 4-2 shows the decay schemes for isotopes at the bottom of the A=67 mass
parabola. It is important to note that good separation from gallium must be achieved due to the
similar half-life, emitted gamma rays, and likely significant production rate of 67Ga.15
Additionally the production of 67Ni (t1/2 = 50s) will contribute to the overall 67Cu production rate
(as the former decays to the latter) resulting a net production of 67Cu greater than its primary
production. Reported here are the results of these studies and the observation of relatively high
chemical extraction efficiency.
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Figure 4-2. Decay schemes for isotopes at the bottom of the A=67 mass parabola.
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Methods
Beam Collection and Calibration
A 25 particle-nA 130 MeV/u 76Ge beam was fragmented using a 510.8 mg/cm2 thick beryllium
production target in the A1900 projectile-fragment separator.16 After fragmentation of the
primary beam, 67Cu was selected using the A1900 with a 236.7 mg/cm2 aluminum wedge in the
center, the focal plane (FP) mass-selection aperture set to 10 mm, and the momentum acceptance
slits open to 2% (full momentum acceptance). Table 4-1 lists the exact experimental parameters
used in the separator and beam line. The beam intensity and purity were measured using the
standard delta-E/Time-of-Flight technique with a silicon-PIN diode in the A1900 focal plane and
cyclotron RF signal prior to delivery of the beam to the experimental end station.16 The
secondary beam was collected for four hours in the liquid water target system before being
transferred to a collection vessel. Four additional collections, each lasting four hours, were made
before shipping samples to Washington University and Hope College for chemical separation
and analysis.
Table 4-1. Experimental parameters for the 67Cu secondary beam at the NSCL.
Block
Description
Value
Primary Beam Target Beryllium
510.797 mg/cm2
D1 Bρ
Dipole magnet
3.2822 Tm
I1 Slits
Momentum acceptance (dρ/ρ)
2.03%
D2 Bρ
Dipole magnet
3.2822 Tm
I2 Slits
Momentum acceptance (dρ/ρ)
2%
I2 Wedge
Aluminum
236.685 mg/cm2
D3 Bρ
Dipole magnet
2.9147 Tm
D4 Bρ
Dipole magnet
2.9147 Tm
CRAD06
BC-400 scintillator (removable) 155 µm
D5 Bρ
Dipole steering magnet
2.9027 Tm
D6 Bρ
Dipole steering magnet
2.9027 Tm
Exit Window
Zirconium
75 µm
Air Gap
Air
89 mm
Water Target Window Kapton
8 µm
Water Target
H2O
73 mm
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At the NSCL there are several non-intercepting beam monitors, Faraday cups, and a BC400 plastic scintillator that can be used to measure beam current. The Faraday cups and
scintillator can be used to determine particles per second, however, only the non-intercepting
beam monitors can be used to measure the beam at full intensity during the sample collections.
Calibration curves had to be established comparing the non-intercepting beam monitors with the
Faraday cups and scintillators in order to calculate particles per second delivered to the water
target station. Two calibrations of the beam monitors were performed during which the beam
was attenuated by 10-1 to 10-3 times the full beam intensity. The currents from Faraday-cups,
non-intercepting beam monitors, and the count rates from the scintillators were recorded and
used to construct linear calibration curves. An aliquot from each of the five water samples was
analyzed with an HPGe detector to determine the amount of 67Cu present in the sample and
decay corrected to the end-of-bombardment in order to determine the beam transport efficiency.

Separations Involving Chelating Disk
All separations using the high-performance extraction disk (3M Empore, MN) were
carried out with 100mL 1.25M ammonium acetate (trace metals grade) and pH adjusted to 5 by
adding acetic acid (trace metals grade). The high-performance extraction disk is functionalized
with iminodiacetic acid groups and at pH 5 the carboxylate groups are negatively charged and
will bind to metal cations. The solution was then drawn through a 25mm diameter extraction
disk in a glass microanalysis vacuum filter holder (Millipore, MA) with vacuum, after the disk
was pretreated by rinsing with 20mL milli-Q water, 20mL 3M nitric acid (trace metals grade), 250mL milli-Q water, 50mL 0.1M ammonium acetate, followed by two additional rinses of 25mL
milli-Q water, allowing the disk to dry between each rinse. When passing the 100mL sample
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through the extraction disk, a new vacuum flask was used to save the eluent so that it could be
analyzed by HPGe detector for radioactivity that did not bind to the extraction disk.

Germanium Separation Validation
Several concentrations of aqueous germanium ranging from 0.04-0.5 ppm in 1.25 M
ammonium acetate were passed through the extraction disk using the method described above.
The chelation disk was analyzed using particle-induced x-ray emission (PIXE) by irradiating the
chelation disk with 3.4 MeV protons for five minutes at beam intensities between 2.25-2.80 nA.
A Si(Li) detector was used to measure the resulting x-rays. The characteristic Kα x-rays for
germanium were analyzed to determine the amount of germanium bound to the chelation disk.

68Ga

and 64Cu Separation Validation
200µCi of 68Ga obtained from a 68Ge/68Ga generator and 200µCi of 64Cu produced at

Washington University in St. Louis were added to 100mL of 1.25M ammonium acetate and
passed through the extraction disk using the method given above. The extraction disk was
surveyed by HPGe for 68Ga and 64Cu using the characteristic gamma rays, 1077.3keV (3.22%)
for 68Ga and 1345.8keV (0.475%) for 64Cu. The extraction disk was returned to the filter holder
and 10mL of 6M hydrochloric acid (trace metals grade) was added to remove 64Cu from the
extraction disk. Both the extraction disk and the filtrate were analyzed by HPGe to measure
amounts of 68Ga and 64Cu present in each.
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Copper, Nickel, and Zinc Separation Validation
Aqueous solutions containing 100µg of copper, nickel and zinc (1000mg/L AAS
Standards, Sigma Aldrich, USA) were added to 100mL 0.1M ammonium acetate solution at pH
5.5 and passed through the chelation disk as described above. 10mL of 6M hydrochloric acid
(trace metals grade) was then added to remove the nickel, copper, and zinc that were bound to
the chelation disk. This solution was then passed through an anion-exchange column containing
2.5g AG1-8X resin (Bio-Rad, USA) and washed with an additional 10mL of 6M HCl to remove
the nickel followed by 10mL of 0.5M HCl to remove the copper. Each 10mL fraction was
brought to dryness by evaporation through overnight heating at 80ºC and reconstituted in 1mL
Ultratrace water (Sigma Aldrich, USA) and analyzed by an HPLC trace metal ion
chromatography method.17

67Cu

Separation
First, each 100mL sample was adjusted to 1.25M solution of NH4OAc by adding 9.6g

trace metals grade ammonium acetate and pH adjusted to 5 by adding trace metals grade acetic
acid. The ~100mL solution was then passed through the chelation disk as described above. The
filter holder was transferred to a clean vacuum flask and 10mL of 6M trace metal grade
hydrochloric acid was passed through to remove the 67Cu along with the nickel and zinc
contaminants. The 6M HCl elution was then transferred to an anion-exchange column with
AG1-X8 resin, the 10mL eluate was collected and then an additional 10mL of 6M hydrochloric
acid was passed through the column and collected. Finally 10mL 0.5M hydrochloric acid was
added to the resin and 1mL fractions of the eluate were collected. All eluates were analyzed for
radiochemical purity by observing the characteristic gamma rays in an HPGe detector.
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67Cu-NOTA-Trastuzumab

Labelling

A 10mg/mL stock of NOTA-NCS was made by dissolving 3.66mg NOTA-NCS
(Macrocyclics, USA) in 366uL Dimethyl sulfoxide. 50uL of 21ug/uL Trastuzumab (Genentech,
USA) was added to 4uL NOTA-NCS stock solution and 96uL 0.1M sodium carbonate pH 9.0
and incubated for 1hr at 37C on a shaking incubator. A Zeba spin desalting column (40kDa
cutoff, 0.5mL) was used to buffer exchange the conjugate into 0.1M ammonium acetate buffer at
pH 5.5. Concentration of the NOTA-Bz-NCS-Trastuzumab was measured using the
bicinchoninic acid (BCA) assay.
The two 1mL 0.5M hydrochloric acid samples with the largest amounts of 67Cu were
brought to dryness and reconstituted using 50uL of 0.1M ammonium acetate at pH 5.5. 5uL was
transferred to a new tube and 5uL 50mmol EDTA was added. The remaining 45uL was added to
a microfuge tube along with 2uL NOTA-Bz-NCS-Trastuzumab and brought to 50uL by adding
0.1M ammonium acetate at pH5.5. Tubes were placed in a shaking incubator at 37ºC for twenty
minutes. This method was adapted from one previously reported by Ferreira et al.18 The
solution containing 67Cu-NOTA-Bz-NCS-Trastuzumab was then challenged with 1μL 50mmol
EDTA. 1uL from each tube was spotted on ITLC paper (Agilent, ) at 2cm from the bottom of
the paper and placed in 1cm running buffer (1:1 10% ammonium acetate and methanol) and ran
until the eluent was 5cm past the starting point (7cm total). The paper was then analyzed by
radio TLC scanner.

7Be

Cross Section Analysis
After allowing the short-lived isotopes to decay, the 100mL eluent from the chelation

disk was analyzed for presence of 7Be using HPGe analysis of the 477 keV gamma ray (10.44%)
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present in spectra collected for 12 and 24 hours. The counts were decay corrected back to the
end of each collection run.

Results
Beam Calibration and Collection
A 76 MeV/A 67Cu secondary beam of 77% purity was selected from a fragmented 76Ge
primary beam using the A1900 fragment separator16 and delivered to the S1 vault where the
water target station was set up to collect the incoming beam. In order to quantify the amount of
67

Cu delivered to the target, calibration curves were developed to convert the signals from the

non-intercepting beam monitors that were continuously operating during beam collections and
the fully-intercepting Faraday-cups or scintillators that could not be in place during the sample
collections.
Two separate calibration methods were used to determine the number of beam particles
delivered to the water target station during two calibration runs performed approximately 12
hours apart. One calibration run was prior to most of the collections and the other was post most
of the collections. In the first method a calibration curve was established to normalize the
proportional data from the non-intercepting beam monitors (Monitors A and B in Figure 4-3) to
the direct measurements of the primary beam current (in nA) with a Faraday cup. The
proportional rates from A and B were integrated over the course of each run and then multiplied
by the conversion factor of 4.1 ± 0.2 x 105 67Cu ions per second per particle-nA of primary beam
(determined by the A1900 operations group) to give the rate of 67Cu atoms delivered. The
second method established calibration curves of two non-intercepting beam monitors A and B
with the focal-plane plastic scintillator that was used to measure the rate of secondary beam
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Figure 4-3: The results of the calibration performed with Method 2 are shown in panels: (A)
Beam Monitor A vs Beam Monitor C, (B) Beam Monitor B vs Beam Monitor C, and (C)
Beam Monitor C vs Scintillator. The results of the calibration performed with Method 1 are
shown in panels: (D) Beam Monitor A vs Faraday-Cup and (E) Beam Monitor B vs FaradayCup.
arriving at the A1900 focal plane in particles per second, and these values were integrated over
the course of each run and multiplied by the purity factor of 77% to obtain the total atoms of
67

Cu delivered to the beam stop. Due to the different working ranges of the detectors used to

measure the beam current, two separate calibration curves had to be used. The first curve
converted the high-intensity beam measured with the non-intercepting beam monitors A and B to
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a medium intensity non-intercepting beam monitor C and the second curve converted the
medium intensity non-intercepting beam monitor C to the low intensity focal-plane scintillator
values in particles per second. The data for both methods for the second calibration run carried
out post-collection are shown in Figure 4-3. Linear functions were found to provide excellent
descriptions of all of the data.
Five collections were performed, each lasting approximately four hours, and the water
from each run was collected as an individual sample for each run. The numbers of 67Cu ions
delivered to the liquid water target system in each run, calculated using the two methods, along
with the values obtained by measuring the gamma-ray activity for aliquots taken from the
samples using an HPGe detector are listed in Table 4-2. The values obtained from the two
calibration curves were averaged for beam monitor A and B in both methods. The average
transport efficiency of the 67Cu secondary beam into the liquid water target system from the
A1900 separator to the water target system was found to be 84 ± 5 %. The modest intensity
reduction occurred between the focal plane and the end station or on the collimator immediately
in front of the water target station entrance window.
Table 4-2: Beam delivered to the water target station calculated using beam monitor A or B
averaging the data from the prior and post collection calibration curves compared to the amount
measured in the water using an HPGe detector.
Method
1A
1B
2A
2B
Average
HPGe
Transport
efficiency

Run 1(kBq)
552 (31)
527 (31)
524 (24)
501 (29)
526 (29)
460 (9)

Run 2(kBq)
551 (31)
527 (31)
523 (24)
501 (29)
525 (29)
452 (9)

Run 3(kBq)
521 (30)
503 (29)
494 (22)
478 (28)
499 (27)
425 (8)

Run 4(kBq)
512 (29)
493 (28)
485 (22)
469 (28)
490 (27)
403 (8)

Run 5(kBq)
524 (30)
500 (29)
497 (23)
476 (28)
499 (28)
397 (8)

87 (5)

86 (5)

85 (5)

82 (5)

80 (4)
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Chemistry
To plan the chemical separation procedure, modeling of the radioisotopes delivered to the
water cell and their decay products was carried out using the LISE++ code with the EPAX3
cross sections and the Nucleonica© decay engine, respectively, as was carried out for the
previous 24Na work.8 The theoretical beam components with half-lives greater than one minute
predicted by the LISE++ code to enter the target water are given in Table 4-3. Note that the
projectile fragment separator tends to deliver more isotonic (same number of neutrons) than
isotopic (same number of protons) contaminants and the primary beam is completely removed.
Table 4-3. Predicted secondary beam components with half-lives greater than one minute.
Nuclide
67
Cu
66
Ni
65
Ni
69
Zn
70
Ga
68
Zn

Half-life
2.58d
2.28d
2.52h
56m
21.14m
Stable

Particles/s
7.33E6 (79.3%)
2.93E5 ( 3.2%)
1.42E5 ( 1.5%)
1.25E6 (13.5%)
1.01E3 ( 0.1%)
2.30E5 ( 2.5%)

All of the different metals were effectively separated from the 67Cu collections using the
methods described below. The chemical separation relied on absorption of the positively
charged cations to a metal-chelation disk, elution, and separation by anion-exchange
chromatography. All methods were validated prior to the 67Cu separations using either nonradioactive species or radioactive surrogate species as tracers. An experiment measuring the
efficiency of removing germanium (primary beam) contamination that would be present in the
primary beam dump in future work at FRIB was determined using PIXE (Particle Induced X-ray
Emission) analysis of 0.04-0.5 ppm germanium that was passed through the chelating disk. The
results showed average germanium retention of only 2.7 ± 0.9 %. This is likely due to the
formation of the neutral compound Ge(OH)4 at pH 519 that did not bind to the negatively charged
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carboxylate groups. In order to test the separation strategy for copper and gallium, 68Ga (t1/2=68
min) obtained from a 68Ge/68Ga generator (Eckert and Ziegler, Germany) and 64Cu (t1/2=12.7 h)
produced at Washington University in St. Louis20 were used as radioactive tracers. Passage of
68

Ga and 64Cu solutions through the chelation disk found that both metals remained bound within

the disk with greater than 99% efficiency; however, 10 mL of 6 M HCl was able to elute, 98 ± 1
% of 64Cu from the disk, while 97 ± 2 % of 68Ga remained fixed to the disk. This is due to Ga3+
having a greater affinity for the chelation disk than Cu2+ and thus Ga3+ would require a higher
chloride concentration to elute. Subsequent separation of copper from zinc and nickel was
obtained using anion-exchange chromatography and verified by ion chromatography.17 The
percent of the initial nickel and zinc concentrations were found to be 4 ± 2 % and 6 ± 4 %,
respectively in the 0.5M HCl fraction. The average copper recovery from this method was
shown to be 86 ± 4%. The resulting separation process is shown schematically in Figure 4-4.

Figure 4-4: Flow chart indicating the separation strategy to recover 67Cu from the aqueous
samples containing 67Cu projectile fragments collected at the NSCL.
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Four of the 67Cu samples were shipped to Washington University in St. Louis and
processed as described above. Table 4-4 contains the values for the recovery of 67Cu from the
aqueous solutions containing the projectile fragments from the NSCL. The average recovery of
67

Cu was found to be 88 ± 3 %, a value in excellent agreement with the tracer studies. The

separated (final) 67Cu fractions were analyzed using an HPGe detector (Canberra, USA)
calibrated using a 2mL mixed source (Eckert and Ziegler, Germany) and no radioactive
impurities were observed. The gallium species had completely decayed from the sample before
processing due to its short half-life and the decontamination factors for nickel and zinc were 20
and 12.5 respectively.
Table 4-4. Chemical recovery of 67Cu from the aqueous solutions produced at the NSCL.

Starting Activity
Recovered Activity
Percent Recovery

Run2(kBq)
452 (9)
388 (8)
86 (2)

Run3(kBq)
425 (8)
380 (8)
89 (3)

Run4(kBq)
403 (8)
353 (7)
88 (2)

Test labeling of an antibody, Trastuzumab, was performed to demonstrate that 67Cu
separated from the water beam dump would be chemically active. Bicinchoninic acid (BCA)
assay showed the final concentration of the conjugated NOTA-Bz-NCS-Trastuzumab to be
7.9mg/mL. The radiochemical yield of 67Cu-NOTA-Bz-NCS-Trastuzumab of 0.5μCi/ug was
found to be greater than 95% by radio instant thin-layer chromatography (ITLC). Figure 4-5
shows the results of fast-protein liquid chromatography of NOTA-Bz-NCS-Trastuzumab, radio
ITLC of 67Cu-NOTA-Bz-NCS-Trastuzumab, radio ITLC of 67Cu-EDTA along with an
illustration of the NOTA chelate bound to Trastuzumab.
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Figure 4-5: (A) Structure of the NOTA-Bz-NCS conjugated to lysine residues on
Trastuzumab. (B) Fast Protein Liquid Chromatography of NOTA-Bz-NCS-Trastuzumab
indicating an intact conjugated antibody. (C) Radio instant thin layer chromatography of
67
Cu-NOTA-Bz-NCS-Trastuzumab challenged with EDTA. The sharp peak at 60mm and the
absence of a later peak signifies a fully labeled antibody. (D) Radio instant thin layer
chromatography of 67Cu-EDTA which serves as a negative control.
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The production of 7Be from reactions of beam on water
One concern with using an aqueous beam dump to collect high-energy fragments is the
buildup of long-lived radioactivity from nuclear reactions with the water. 7Be (t1/2=53.3 d) is
produced in reactions between essentially all fast ion beams and water. While 7Be can be easily
separated from the 67Cu in this experiment, there may be instances where this contaminant could
interfere with the harvesting process. The predicted production rate of 7Be with an incident
medium mass beam (A≈67) is 6.4 x 10-4/incident ion.15 The 7Be concentrations in the present
samples were measured using HPGe spectroscopy and showed that the production of 7Be per
incident ion on water was 5 ± 2 x 10-4.
In addition to 7Be, 11C and 13N were observed byproducts of the interaction of the
secondary beam on water. Due to the short half-life of these isotopes, they were not observed on
the HPGe detector, however their decay was observed using a CsF detector that monitored the
collection vials upon completion of a four-hour collection. Future experiments will be designed
in order to quantify the amount of these short-lived byproducts that are produced.

Discussion
A liquid water target station previously designed to collect fast, secondary beams from
the National Superconducting Cyclotron Laboratory was used to collect five samples of 67Cu.
The five collections lasted for four hours each, and the samples were then shipped to Hope
College and Washington University in St. Louis for further analysis and chemical separation.
67

Cu was effectively separated from the beam contaminants with an average recovery of 88 ± 3

%. The resulting 67Cu was then bound to NOTA-Bz-NCS-Trastuzumab with a radiochemical
yield of >95%. These results demonstrate the feasibility of harvesting useful radioisotopes from
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the aqueous beam dump at the Facility for Rare Isotope Beams (FRIB) now under construction at
Michigan State University. Future experiments will be performed to collect and separate 67Cu
from an unanalyzed, i.e., mixed secondary beam to better mimic the conditions that would be
present in the actual FRIB beam dump.
The overall production of 67Cu at the NSCL was estimated to be 7.33 x 106 pps for the
76

Ge beam and experimental conditions reported here16. An observed rate of 1.13 x 107 pps of

67

Cu was measured during this experiment which closely matches the predicted yield for the

NSCL. Since the same codes are used to estimate yields at FRIB, this bodes well for an expected
production rate of ~2Ci of 67Cu in the primary beam dump at saturation during regular
operations. Similarly the production of 7Be was also measured to be 5.7 x 103 pps, which also
compare favorably with the predicted production rate of 4.7 x 103 pps.
While this proof-of-principle experiment made use of a water target cell to collect the
beam in a small volume of non-circulating water, in the future at the Facility for Rare Isotope
Beams there will be ion exchangers present which could act as potential sources for isotope
harvesting. Additional research will be needed in order to determine how much 67Cu (and other
isotopes of interest) can be extracted from the resin for the purposes of isotope harvesting.
The most promising radionuclides for isotope harvesting from FRIB would be those
which cannot be produced easily by other means, such as with a reactor or small medical
cyclotron. Additionally, isotope availability may depend on the needs of the primary user, how
pure the isotopes need to be and the frequency of production. While this is a very promising
source of isotopes for many fields, it should be noted that isotopes obtained in this manner will
not be available continuously due to an incompatibility with the primary beam requirements.
Thus, due to the nature of this technique, it is likely that medium- to long-lived research isotopes,
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like the one studied here, will be the most promising targets for isotope harvesting from heavyion fragmentation facilities.
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Chapter 5
Harvesting 67Cu from the Collection of an Unanalyzed Secondary Beam at the National
Superconducting Cyclotron Laboratory
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Introduction
The collection of the analyzed 67Cu secondary beam at the NSCL, discussed in Chapter 4,
was an idealized case. The separation from numerous beam contaminants must be performed to
better address the feasibility of harvesting 67Cu from an aqueous beam dump. The fragment
separator at the FRIB facility1,2 will operate similarly to the A1900 at the NSCL.3 The
fragmented primary beam will travel through a dipole magnet to remove the primary beam and
the fragmented isotopes that differ in magnetic rigidity from the isotope of interest to the end
user. At the FRIB facility the discarded isotopes will go into an aqueous beam dump. Because
an aqueous beam dump does not currently exist at the NSCL the normal beam separation process
must be manipulated to obtain an impure (unanalyzed) secondary beam.
The aluminum wedge in the A1900 (Figure 5-1)3 is an important part of the beam
purification process. Several different isotopes will have a similar magnetic rigidity to the one
selected for the isotope of interest after the fragmentation process, however they will differ in
charge. The energy of the ions is reduced as they transfer energy to the electrons in the medium

Figure 5-1. Schematic of the A1900 fragment separator at the NSCL.3 The aluminum
wedge is shown.
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(this energy loss is well described by the Bethe-Bloch equation). This loss of energy changes
each ion’s momentum and its magnetic rigidity (the reduction in magnetic rigidity is proportional
to the momentum change if the charge state is not changed). At the energies of the present work,
the ions are fully stripped so the charge, Q, is equal to the atomic number, Z. The beam is
usually purified by passing it through another set of dipoles set to pass the rigidity of the isotope
of interest after it passes though the wedge absorber. An unanalyzed beam can be obtained by
removing the aluminum wedge. Collection of this unanalyzed secondary beam using the water
target station, discussed in Chapter 3, is a better representation of the conditions that would be
present in the beam dump at FRIB.4
Previously, we were able to separate 67Cu from nickel, zinc, germanium, and gallium
collected from an analyzed secondary beam using a two-part chemical purification process. A
more complicated procedure had to be developed for separation of 67Cu from the unanalyzed
beam, which consisted primarily of first-row transition metals. Most of the elements present in
the secondary beam consisted of one or more radioactive isotopes. Characteristic gamma rays
for each radioisotope were analyzed to monitor the separation of 67Cu from the different
elements, which ranged in atomic number from 19 to 34.
Three separate collections were obtained and shipped to Washington University in St.
Louis for chemical separation and gamma analysis.

67

Cu was chemically separated from the

beam contaminants with high radiochemical purity and used to radiolabel an anti-EGFR antibody
(Panitumumab).5 Biodistribution studies were conducted with this radiopharmaceutical using
colon cancer xenografts to demonstrate proof of concept.
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Materials and Methods
Beam Collection
In a similar manner to the method discussed in Chapter 4, a 25 particle-nA 130 MeV/u
76

Ge beam was fragmented using a 493 mg/cm2 thick beryllium production target in the A1900

projectile-fragment separator.3 The aluminum wedge was removed from the center of the A1900
to obtain an unanalyzed secondary beam. The focal plane (FP) mass-selection aperture was set
to 10 mm and the momentum acceptance slits open to 2% (full momentum acceptance). The
experimental parameters for the separator and beam line are listed in Table 5-1. Note that the
two sets of dipoles D1-D2 and D3-D4 are set of the same rigidity. This arrangement passes 92.9
MeV/u 67Cu29+, which corresponds to a momentum of 28.5 GeV/c, and other ions with different
momenta but the same rigidity. The slits fix the range of momenta that are passed to ± 2% of
value of each ion that corresponds to a Brho = 3.2822 Tm. The beam intensity and purity were
measured using the standard delta-E/Time-of-Flight technique with a silicon-PIN diode in the
A1900 focal plane and cyclotron RF signal prior to delivery of the beam to the experimental end
station.3
Table 5-1. Experimental parameters for the 67Cu secondary beam at the NSCL.
Block
Description
Value
Primary Beam Target
Beryllium
493 mg/cm2
D1 Bρ
Dipole magnet
3.2822 Tm
I1 Slits
Momentum acceptance (dρ/ρ)
2.03%
D2 Bρ
Dipole magnet
3.2822 Tm
I2 Slits
Momentum acceptance (dρ/ρ)
2%
D3 Bρ
Dipole magnet
3.2822 Tm
D4 Bρ
Dipole magnet
3.2822 Tm
D5 Bρ
Dipole steering magnet
3.2822 Tm
D6 Bρ
Dipole steering magnet
3.2822 Tm
Exit Window
Zirconium
75 µm
Air Gap
Air
89 mm
Water Target Window
Tantalum
12.7 µm
Water Target
H2O
73 mm
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Three separate collections of the secondary beam were made using the water target
system as described in Chapter 3 with two modifications. Due to the higher intensity of the
beam compared to previous experiments, a 12.7 μm tantalum foil was used in place of the 8μm
kapton film. Additionally, room temperature water was circulated through the water target cell
at 100 mL/min via a Teflon tube, to keep the collection water below 30ºC.

Beam Current and Collection Efficiency
Several carbon disks (1.245” in diameter and 0.4” thick) were used to collect the
incoming beam at various times throughout the experiment. A rotating wheel with 12 holes
1.25” in diameter, containing the carbon disks in alternating positions, was placed between the
zirconium exit window and the entrance window to the water target station. The rotating wheel
could be controlled remotely from outside of the experimental vault. A position consisting of an
empty hole was used during aqueous beam collection. At various times during the experiment,
the wheel was rotated so that one of the carbon disks was in line with the entrance window. The
secondary beam was collected by the carbon disk for 2-5 minutes before returning the wheel to
an empty position. The carbon disks were shipped to Hope College for gamma analysis using an
HPGe detector to obtain a beam current (67Cu atoms/second).
The beam current was measured by several non-intercepting beam monitors located
throughout the A1900.3 Because the non-intercepting beam monitors measured an intensity that
was proportional to the beam current and not the actual beam current, a calibration factor had to
be obtained to relate the two parameters. The intensity measured by the beam monitors was
averaged for the time interval corresponding to the respective carbon disk irradiation. The
calibration factor was obtained by dividing the measured 67Cu atoms per second by the average
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intensity measured by the beam monitors. To calculate the total amount of 67Cu delivered to the
water target station, the beam intensities measured throughout the experiment using the nonintercepting beam monitors were integrated over the total time of collection and multiplied by
the calibration factor. The 67Cu beam collection efficiency was calculated as the total number of
67

Cu atoms collected, as measured by HPGe, divided by the total number of 67Cu atoms

delivered.

Preliminary Separation Experiments
The first step in developing a separation strategy was to monitor where cobalt, iron, and
manganese appeared in the separation strategy used in Chapter 4. 10 μg of Cu, Zn, Ni, Co, Fe,
and Mn were added to 100 mL of 1.25 M NH4OAc pH 5 and passed through a chelation disk as
described previously. At pH 5 the carboxylate functional groups on the chelation disk are
negatively charged, thus attracting positively charged ions. The metal ions in the above solution
existed as 2+ ions with the exception of manganese, which likely existed as both a 2+ ion and as a
MnO molecule. The addition of 10 mL 6 M HCl to the chelation disk extracted the 2+ metals
that were chelated by the disk without removing the 3+ metals from the disk. Following passage
through the chelation disk the 6M HCl fraction was added to an anion exchange column
containing 2.5g of AG1-X8 resin (Bio-Rad, CA). The elution constants of these metals for
quaternary amine functionalized resin vary with the concentration of hydrochloric acid.6
Varying amounts of 6M, 4M, 2.5M and 0.5M HCl were used to elute the different metallic ions
from the anion exchange resin. Each fraction collected was evaporated to dryness and
reconstituted in 5 mL of 3% HNO3 (the metallic ions existed as Cu2+, Ni2+, Zn2+, Co2+, Mn2+,
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Fe2+). An aliquot of each fraction was diluted by a factor of 500 and measured via Ion
Chromatography7 to monitor the separation of the different elements.
The separation of cobalt from copper was more difficult than with the other divalent
metals because the elution constants of these two metals are similar.6 Because the elution
constant for cobalt rises at a steeper rate than that of copper between 6M and 3M hydrochloric
acid, we varied the concentration of HCl in this range monitoring the copper-cobalt separation
with the radiotracers 55Co and 64Cu. 3.7 MBq of 55Co and 64Cu in 10 mL of 6M HCl were added
to an anion exchange column with 2.5g of AG1-X8 resin and the eluate was collected. Three
additional fractions of 10 mL of 6M HCl were added to the resin and their eluate was collected.
10 mL of 4M HCl were added to the resin and the eluate was collected. Then, 10 mL of 2.5M
HCl were added to the resin and the eluate was collected. Finally, 10 mL of 0.5M HCl were
added to the resin and the eluate was collected. The eluate from each fraction was analyzed by
an HPGe detector to detect the characteristic gamma rays of 64Cu (1345 keV) and 55Co (931,
477, and 1408 keV).
The chemistry of vanadium is much more complex than the metals described above and it
is likely that vanadium deposited in the aqueous beam dump will exist in several different charge
states. The ion chromatography method cannot be used to measure the concentration of
vanadium, therefore another method had to be developed to monitor the separation of vanadium.
Vanadium was oxidized to the +5 oxidation state by the addition of hydrogen peroxide. A UVVis spectrophotometer at 450nm was used to obtain an absorbance for this solution. Calibration
curves for vanadium in 6M, 2.5M, and 0.5M hydrochloric acid were obtained for concentrations
ranging from 2mg/L to 12mg/L using an atomic absorbance standard of vanadium. Linear
calibration curves were achieved.
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A 100 mL 1mg/L solution of vanadium in 1.25M NH4OAc pH 5 was passed through a
chelation disk. 10 mL of 6M HCl were then passed through the disk and collected. 20μL of
H2O2 were added to a 1 mL aliquot of the eluate and its absorbance measured at 450nm. The
remaining 9 mL of 6M HCl were added to a column containing 2.5g AG1-8X resin. Two
additional 10 mL 6M HCl fractions followed by a 10 mL 2.5M fraction were eluted from the
column and 20μL of H2O2 were added to 1mL aliquots from each fraction and their absorbance
measured at 450nm the absorbance peak for V(V) complexes.
Titanium in an aqueous solution is readily oxidized to TiO2, which is insoluble in water.
However, the concentration of titanium will be very low in the beam dump, therefore it is
expected that TiO2 will be soluble at this concentration. As with vanadium, titanium
concentration cannot be measured using ion chromatography. However in acidic medium and in
the presence of hydrogen peroxide titanium exhibits a bright yellow color representative of its +4
oxidation state. Calibration curves were made in 6M, 2.5M, and 0.5M HCl for concentrations
ranging from 2mg/L to 12mg/L. Linear curves were obtained as the plot of absorbance at 405nm
vs concentration.
An atomic absorption standard of TiO2 was used to make a 100mL 1mg/L solution of
titanium in 1.25M NH4OAc at pH 5. This was passed through a chelation disk followed by 10
mL 6M HCl. A 1mL aliquot of the 6M HCl eluate was collected and 20μL H2O2 were added.
The absorbance was measured at 405nm. The remaining 9mL of 6M HCl were subjected to
anion exchange chromatography in the same manner as described for vanadium. 20μL H2O2
were added to a 1mL aliquot from each fraction and their absorbance measured at 405nm the
absorbance peak for Ti(IV) complexes.
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67Cu

Separation
First, each 100mL collection was adjusted to 1.25M solution of NH4OAc by adding 9.6g

trace metals grade ammonium acetate and pH adjusted to 5 by adding ~3mL trace metals grade
acetic acid. The ~100mL solution was then passed through the chelation disk as described in
Chapter 4. The filter holder was transferred to a clean vacuum flask and 10mL of 6M trace
metal grade hydrochloric acid were passed through to remove the 67Cu and other 2+ metal
contaminants bound to the chelation disk. The 6M HCl elution was then transferred to an anionexchange column with AG1-X8 resin, the 10mL eluate was collected and then two additional
10mL fractions of 6M hydrochloric acid were passed through the column and collected. Next
10mL 2.5M hydrochloric acid were added to the resin and the eluate was collected. Then 10mL
0.5M HCl were added to the resin and the eluate collected. All eluates were analyzed for
radiochemical purity by observing the characteristic gamma rays in an HPGe detector.

Conjugation of NOTA-Bz-NCS to Panitumumab
A 10mg/mL stock solution of NOTA-Bz-NCS was made by dissolving 4.18mg NOTABz-NCS (Macrocyclics, USA) in 418μL of 0.1M sodium carbonate buffer (pH9). 50μL of
20μg/μL Panitumumab (Genentech, USA) were added to 10μL NOTA-Bz-NCS stock solution
followed by the addition of 50μL of 0.1M sodium carbonate buffer (pH 9.0) and incubated at
37ºC for 1 hr in a shaking incubator. A Zeba spin desalting column (40K MWCO, 0.5mL) was
used to buffer exchange the conjugate into 0.1M ammonium acetate buffer (pH 5.5). The
concentration of the NOTA-Bz-NCS-Panitumumab conjugate was measured using the Bradford
assay.8
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Evaluation of Immunoreactivity
The immunoreactivity of the conjugated NOTA-Bz-NCS-Panitumumab was measured to
verify that the conjugation did not affect the antigen-binding properties of the antibody. This
was done by incubating different concentrations of 64Cu-NOTA-Bz-NCS-Panitumumab with a
fixed number of antigens (cells). Method 3 as described by Konishi et al9 was used to measure
the immunoreactive fraction (IF) of the radiolabeled antibody. The final effective specific
activity of 64Cu-NOTA-Bz-Panitumumab was 185 kBq/μg. Radiolabeling was confirmed to be
>99% by radio thin-layer chromatography as described in Chapter 4. The radiolabelled
Panitumumab was brought to a final concentration of 4.18 μg/mL in 0.1M NH4OAc pH 5.5.
Serial dilutions were performed so that solutions ranging from 0.0625 μg/mL through 4.18
μg/mL were obtained. 50μL of each concentration was added to 500μL of 3 x 106 HCT-116
cells suspensions containing 0.1% bovine serum albumin in PBS, in triplicate. Cell solutions
were placed on a shaker at room temperature and incubated for 2 hours. Cells were pelleted at
1,000 x g for 3 minutes and the supernatant was removed. Cells were then washed three times
with 500μL of phosphate buffered saline, pelleting and removing the supernatant between each
wash. Standards containing the initial activity of each concentration along with the cell pellets
were counted on a gamma counter. The immunoreactive fraction was calculated using equation
8 (Equation 5-1) as described by Konishi et al9 where B is bound antibody, T is total antibody,
Fmax is the maximum number of binding sites, r is the immunoreactive fraction, and Ka is the
association constant. The ratio of bound vs. total antibody was graphed against the total
antibody (pmol) in Prism 6 (Graphpad, California). Fmax, r, and Ka were used as the fitting
parameters in order to obtain a best fit curve.
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Equation 5-1

Animal Models
All animal care was performed as stated in the Guide for Care and Use for Laboratory
Animals by the National Institutes of Health under a protocol approved by the Animal Studies
Committee at Washington University in St. Louis. Female Athymic Nu/Nu mice (National
Cancer Institute, USA) aged 6-9 weeks were anesthetized with a ketamine/xylazine cocktail
(VEDCO, USA). 100 μL of approximately 3 x 107 cell/mL HCT-116 colon cancer cells
suspended in saline were subcutaneously injected into the shoulder. Tumors were allowed to
grow for two weeks before biodistribution studies.

Radiolabeling and Biodistribution of 67Cu-NOTA-Bz-Panitumumab
The 2.5M HCl fractions from the three separations were mixed together, brought to
dryness, and reconstituted in 30μL of 0.1M HCl (67Cu existed as 67Cu2+). 25μL (451 kBq) of
Cu was added to 25μL of 0.5M NH4OAc and the final solution had a pH of 5.5 (at pH 5.5 the
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carboxylate groups on NOTA are negatively charged allowing Cu2+ to be chelated). 111 μL
5.5mg/mL NOTA-Bz-Panitumumab was added to the mixture and incubated at 37ºC for 30
minutes. Radiolabeling was confirmed using radio thin-layer chromatography. The solution was
brought to 400μL by the addition of saline and non-specifically bound 67Cu was challenged with
EDTA (final EDTA concentration of 1mM).
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113 kBq of 67Cu-NOTA-bz-Panitumumab was injected into three HCT-116 colon cancer
xenografted mice via the tail vein. Biodistribution studies were performed at five days post
injection. Organs and tumors were harvested and weighed. The radioactivity associated with
each organ was assayed in a gamma counter, background and decay corrected, to determine the
percentage of injected dose per gram of organ (%ID/g).
Results
Beam Collection
A 76 MeV/u unanalyzed 67Cu secondary beam with a purity of 2.6% was selected from a
fragmented 76Ge primary beam and delivered to the S1 vault where the water target station was
set up to collect the incoming beam. The average calibration factors measured for Beam
Monitors A and B were 2.6 ± 0.5 x 109 and 6 ± 1 x 1012 respectively. The data from each of the
irradiated carbon disks is listed in Table 5-2.
Table 5-2. Beam Current data obtained from irradiation of the carbon disks.
Beam
Monitor A
Total 67Cu
Collection
Calibration
67Cu atoms/s
Sample
Atoms
Time (s)
Factor
9
6
Disk 1
1.41 (0.03) x 10
300
4.7 (0.1) x 10
1.97E+09
8
6
Disk 2
6.0 (0.1) x 10
120
5.0 (0.1) x 10
2.40E+09
Disk 3
1.13 (0.02) x 109
120
9.4 (0.2) x 106
2.91E+09
8
6
Disk 4
8.0 (0.2) x 10
120
6.6 (0.1) x 10
3.47E+09
9
6
Disk 5
1.61 (0.03) x 10
300
5.4 (0.1) x 10
2.29E+09
8
6
Disk 6
6.5 (0.1) x 10
120
5.4 (0.1) x 10
2.62E+09

Beam
Monitor B
Calibration
Factor
4.78E+12
5.54E+12
7.2E+12
8.94E+12
5.5E+12
6.09E+12

An aliquot of 1 mL from each of the collections was analyzed by an HPGe detector to
measure total 67Cu activity using the characteristic gamma rays (91.3, 93.3, 184.6, 300.2, and
393.5 keV). It is important to note that 67Ga was present in the secondary beam. Because
greater than 99% of the gallium remains bound to the disk and more than 99% of the copper
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elutes from the disk upon the addition of 6M HCl, the contribution to the above characteristic
gamma rays from 67Ga could be calculated and used to correct the total 67Cu activity. These
results were compared to the amount of 67Cu delivered to the water target station for each
collection and are listed in Table 5-3. The average collection efficiency was found to be 115 ±
18 %.
Sample
Z001I-C (Mbq) Z030F-C (MBq) HPGe (MBq)
Collection 1
1.1 (0.2)
1.2 (0.3)
1.16 (0.03)
Collection 2
0.8 (0.2)
0.8 (0.2)
0.881 (0.003)
Collection 3
0.6 (0.1)
0.6 (0.1)
0.799 (0.002)

Collection Efficiency
101 (15)
112 (17)
133 (20)

Development of a Chemical Separation Strategy
The theoretical beam contaminants delivered to the water cell and their decay products
were modeled using the LISE++ code with the EPAX3 cross sections and the Nucleonica©
decay engine, respectively, as was carried out for the previous experiments in Chapters 3 and 4.
The theoretical contaminants at three days post irradiation are listed in Table 5-4. The
separation strategy consists of two parts. First passing the liquid through a chelation disk
functionalized with iminodiacetic acid groups. At pH 5, the carboxylate groups are negatively
charged, which results in the binding of positively charged metal ions. Neutral or negatively
charged species will not bind to the chelation disk and therefore can be separated from the
isotope of interest 67Cu2+. The second part consists of using hydrochloric acid to remove the 2+
metal ions from the chelation disk. This is followed by passing the eluent through a column
containing quaternary amine functionalized anion exchange resin. At high chloride
concentrations many metals form negatively charged metal chloride species such as MCl3- or
MCl42-. Varying the concentration of chloride allows for separation of the first row transition
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metals, as each metal forms these negatively charged complexes at different chloride
concentrations. As the chloride concentration is lowered, metals exist primarily as cationic
species and are eluted from the resin. Preliminary experiments determined that > 99% of the
titanium, vanadium and manganese would be separated from 67Cu with the chelation disk and the
first three 6M HCl fractions. This resulted from the formation of TiO2, H2VO4-, Mn2+, and
MnO210-12 in aqueous solutions at pH 5. Iron, existing as Fe2+, was found to elute from the
column in the 0.5M HCl fraction. The best separation achieved for cobalt and copper was the
use of three 6M HCl fractions, which removed ~80% of the cobalt. Arsenic, in aqueous
solutions at pH 5, exists both as the neutral compound H3AsO3 and the negatively charged
complex H2AsO4-. These arsenic species were expected to pass through the chelation disk.13
Therefore, the separation strategy developed for the separation of 67Cu from the aqueous beam
dump consisted of the use of the chelation disk, followed by anion exchange using three fractions
of 6M HCl, a 2.5M HCl fraction, and a 0.5M HCl fraction.

Separation of 67Cu from the Secondary Beam Collections
Separation of 67Cu was performed as discussed in the methods above. Figure 5-2 shows
the separation profile of all the beam contaminants as measured using HPGe analysis of the
characteristic gamma rays for one or more isotopes of each element. HPGe spectra were
obtained immediately after separation. Additional HPGe spectra taken for longer time intervals
were obtained after the short-lived isotopes decayed to measure the concentrations of long-lived
isotopes. Figure 5-3 shows the HPGe spectra taken for each part of the separation.
Each gamma ray was assigned to an isotope by using the Lawrence Berkeley National
Laboratory Radiation Search database.14 In the case where different isotopes had gamma rays
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that could not be resolved, other gamma rays were used to calculate the activity in order to
correct for the peak contribution from both radioisotopes. All radioisotopes measured were
corrected for decay while counting and results were decay corrected to the end of bombardment.
The identifying isotopes, theoretical amount of each element with respect to 67Cu, and the final
contamination to 67Cu ratios are listed in Table 5-4. The success of the chemistry is measured
by the ratio of the final contaminant concentration vs the initial contaminant concentration.
There are many cases where this ratio, the decontamination factor, is so large that no residual
activity can be measured. The worst case observed was for cobalt, where the final solution could
only be decontaminated by a factor of 3.
74 ± 4% of the 67Cu was obtained in the 2.5M fractions with a radiochemical purity of
>99%. The other contaminants present in the 67Cu fractions measured by HPGe for 12 hours and
decay corrected to end of bombardment were 58Co (0.07%), 48Sc (0.06%), 47Sc (0.06%), and
72

Ga (0.30%). No additional radioactive contamination was detected in the 2.5M HCl 67Cu

fractions. The 67Cu fraction was brought to dryness by heating followed by reconstitution in
20μL 0.1M HCl.
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Figure 5-2. Flow chart showing the chemical separation of the isotopes present in each of the collections.
Labels a-i correspond to the spectra shown in Figure 5-3.
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Table 5-4. Contaminating elements present in the secondary beam collections at three days post
bombardment, the isotopes used to follow the separation of each element, and the initial and final
contaminant to 67Cu ratios.
Contaminating
Identifying
Initial Contaminant
Final Contaminant
Element
Isotopes
to 67Cu Ratio
to 67Cu Ratio
69
Ge
Ge
30
Below Detection
74
As
As
24
Below Detection
72
Ga
Ga
5.48
0.1096
69M
Below Detection
Zn
Zn
5.48
57
Below Detection
Ni
Ni
3.55
59
Below Detection
Fe
Fe
2.58
Cu
Cr
K
Ca
V
Sc
Mn
Se
Co
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Cu
51
Cr
43
K
47
Ca
48
V
46
47
Sc, Sc, 48Sc
52
Mn
75
Se
58
Co

67Cu-NOTA-Bz-Panitumumab

1.87
1.13
0.81
0.81
0.42
0.39
0.32
0.13
0.06

1.87
Below Detection
Below Detection
Below Detection
Below Detection
0.0078
Below Detection
Below Detection
0.018

Labeling and Biodistribution Studies

The final concentration of the NOTA conjugated Panitumumab was measured via the
Bradford assay to be 5.55mg/mL. The immunoreactivity (measurement of the retained
functionality of the antibody after conjugating with NOTA) was measured to be 97 ± 2 % and
the data used to obtain this value is shown graphically in Figure 5-4. NOTA-Bz-Panitumumab
was radiolabeled with 67Cu at a final specific activity of 740Bq/μg.
113 kBq of 740 Bq/μg 67Cu-NOTA-Bz-Panitumumab was injected into three colon
cancer xenografted mice. At 5 days post injection the mice were sacrificed and their organs
assayed for % Injected Dose per gram of tissue. Biodistribution data for 67Cu-NOTA-BzPanitumumab is shown in Figure 5-5. The %ID/g of the tumor was found to be 12.5 ± 0.7 %,
which is in strong agreement with results reported by Chang et al.5
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Figure 5-4. The ratio of bound vs total 64Cu-NOTA-Bz-Panitumumab vs. the total amount of
antibody (pmol). Immunoreactivity was calculated using method 3 as described by Konishi
et al.9
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Figure 5-5. Biodistribution of 67Cu-NOTA-Bz-Panitumumab in HCT-116 colon cancer
xenografts. The %ID/g of the tumor was measured to be 12.5 ± 0.7 %.
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Discussion
Our results show that 67Cu was separable with high radiochemical purity from an aqueous
beam dump containing many contaminants. An anti-EGFR antibody, Panitumumab, was
successfully conjugated with NOTA-Bz-NCS without affecting its antigen binding properties.
The purified 67Cu was then used to radiolabel the Panitumumab conjugate to obtain a
biodistribution profile for 67Cu-NOTA-Bz-Panitumumab in HCT-116 colon cancer xenografted
mice as a proof-of-concept.
The effective specific activity of 67Cu-NOTA-Bz-Panitumumab was low (20nCi/μg).
Since the elements in the secondary beam had one or more isotopes that could be used as a
radiotracer, and the radiochemical purity of 67Cu was measured to be greater than 99%, it is
suspected that the lower specific activity did not result from poor separation of the secondary
beam. One potential source of stable contamination is the tantalum foil that was used as the
entrance window to the liquid water target cell. Other potential sources of contamination are
from the glassware, vials, or chemicals used in the separation process. The final 67Cu fraction
has been shipped to Missouri University Research Reactor (MURR) for elemental analysis using
inductively coupled plasma mass spectrometry.
One limitation of this study was the contaminants present in the beam as they only
consisted of elements located in period four of the periodic table. It is estimated that ~60% of
the primary beams supplied at FRIB will be uranium. Fragmentation of the uranium beam will
create waste isotopes of all elements lower in mass than uranium. The additional contamination
generated from uranium fragmentation will require additional separation steps and further loss of
67

Cu in the process. Future research should include the separation efficiency for 67Cu from
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fission fragments along with decontamination factors for elements between selenium and
uranium in the periodic table.
Another limitation of this study was the exclusion of mixed bed resin as a first step in the
separation strategy. At the FRIB facility the aqueous beam dump will be circulated through
columns containing mixed bed resins as a way to remove the radioactivity from the water.
Isotopes of interest for applications research will have to be eluted from this resin. Future
experiments should be performed using the mixed bed resin that will be employed at FRIB.
In conclusion, 67Cu was obtained with high radiochemical purity and the decontamination
factors for elements from potassium through selenium were determined.

67

Cu was acquired in

the proper chemical form to be used for radiolabeling molecular probes. These studies support
the hypothesis that 67Cu can be harvested from the aqueous beam dump at FRIB for use in preclinical research.

102

References
1

Morrissey, D. Status of the FRIB project with a new fragment separator. Journal of
Physics: Conference Series 267, 012001, doi:10.1088/1742-6596/267/1/012001 (2011).

2

M. Hausmann, A. A., A. Amthor, M. Avilov, L. Bandura, R. Bennett, G. Bollen, T.
Burgess, S. Chouhan, V. Graves. Design of the Advanced Rare Isotope Separator ARIS
at FRIB. Nuclear Instruments and Methods in Physics Research Section B: Beam
Interactions with Materials and Atoms 317, 349-353, doi:

10.1016/j.nimb.2013.06.042

(2013).
3

Morrissey, D. J., Sherrill, B. M., Steiner, M., Stolz, A. & Wiedenhoever, I.
Commissioning the A1900 projectile fragment separator. Nucl Instrum Meth B 204, 9096, doi:Doi 10.1016/S0168-583x(02)01895-5 (2003).

4

Ronningen, R. Isotope Inventories in Cooling Loop. 2nd Workshop on Isotope
Harvesting at FRIB (2012).

5

Chang, A. J., Silva, R. A. D. & Lapi, S. E. Development and Characterization of 89ZrLabeled Panitumumab for Immuno–Positron Emission Tomographic Imaging of the
Epidermal Growth Factor Receptor. Molecular Imaging 0, 1-11,
doi:10.2310/7290.2012.00016 (2012).

6

Kraus, K. A. & Moore, G. E. Anion Exchange Studies. VI. The Divalent Transition
Elements Manganese to Zinc in Hydrochloric Acid. Journal of the American Chemical
Society 75, 1460-1462, doi:10.1021/ja01102a054 (1953).

7

Mastren, T. et al. Specific activity measurement of (6)(4)Cu: a comparison of methods.
Applied radiation and isotopes : including data, instrumentation and methods for use in

103

agriculture, industry and medicine 90, 117-121, doi:10.1016/j.apradiso.2014.03.016
(2014).
8

Bradford, M. M. A rapid and sensitive method for the quantitation of microgram
quantities of protein utilizing the principle of protein-dye binding. Analytical
biochemistry 72, 248-254 (1976).

9

Konishi, S. et al. Determination of immunoreactive fraction of radiolabeled monoclonal
antibodies: What is an appropriate method? Cancer Biother Radio 19, 706-715, doi:DOI
10.1089/cbr.2004.19.706 (2004).

10

Sakka, S. Handbook of sol-gel science and technology : processing, characterization,
and applications. (Kluwer Academic Publishers, 2005).

11

Tufekci, N. & Celik, S. O. The Effects of Some Inorganic and Organic Species on
Oxidation with Atmospheric Oxygen of Manganese in Natural Water. Pol J Environ Stud
20, 201-207 (2011).

12

Tella, E. et al. The Mechanism of Retention of Vanadium Oxo-Species at the "Titanium
Oxide/Aqueous Solution" Interface. Global Nest J 12, 231-238 (2010).

13

Ngai, T. K. K. ARSENIC SPECIATION AND EVALUATION OF AN ADSORPTION
MEDIA IN RUPANDEHI AND NAWALPARASI DISTRICTS OF NEPAL MASTER OF
ENGINEERING IN CIVIL AND ENVIRONMENTAL ENGINEERING thesis,
Massachusetts Institue of Technology, (2001).

14

Firestone, R. B. & Ekstrom, L. P. Radiation Search, <http://ie.lbl.gov/toi/radsearch.asp>
(2004).

104

Chapter 6
Cyclotron production of high specific activity 55Co and the
evaluation of the stability of 55Co metal-chelate-peptide complexes in
vivo
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Introduction
Recently interest in positron emitting metals has increased due to their longer half-lives
when compared to traditional PET isotopes such as 18F, 11C, and 15O. Currently the most
common radiometals used in PET imaging are 64Cu, 68Ga, 89Zr, and 86Y with 64Cu, 68Ga, and 89Zr
being used in clinical trials. The chemistry of each metal is different and chelates need to be
optimized for the radiometal of interest. Therefore when developing new positron-emitting
radiometals for use in pre-clinical research it is important to establish chelators that provide
stable metal-chelate complexes in vivo.
55

Co is an isotope also of interest for PET imaging. It has a half-life of 17.5 hr, a positron

branching ratio of 77%, and an average positron energy of 570 keV (Figure 6-1) qualities that
make it a candidate for labelling peptides, small molecules, and antibody fragments.1-6

55

CoCl2

has also been used clinically to image ischemia in stroke patients7-10 and in late-onset epileptic
seizures.11 With the growing interest in 55Co as a PET imaging agent, it is important to study the
pre-clinical pharmacological properties of this isotope. Information on the biodistribution of free
55

CoCl2 along with the stability of 55Co metal-chelate complexes in vivo is required to design

imaging agents employing this isotope.
Co can be made via several nuclear reactions such as 58Ni(p,α)55Co, 56Fe(p,2n)55Co, and

55

54

Fe(d,n)55Co.12-19 The 54Fe(d,n)55Co has the highest measured cross section at low energies,3,20

however 54Fe has a low natural abundance and thus this target may be cost-prohibitive for
routine production in most laboratories. The 56Fe(p,2n)55Co reaction also creates undesirable
56

Co via the 56Fe(p,n)56Co reaction.

56

Co is a positron emitting isotope with a half-life of 77d,

many high energy photons, and chemically inseparable from 55Co. The proton reaction on 58Ni
has a higher cross section at lower energies than the proton reaction on 56Fe16,18,19 making it more
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desirable for low-energy (15 MeV) cyclotrons. This method also produces a small amount of a
side product, 57Co (t1/2=271.8d).

57

Co decays 100% by electron capture and has a low-energy

gamma ray of 122 keV. Therefore the nickel route is a better option for the production of 55Co
for applications in PET imaging.

-

55Co

EC 23%
β+ 77%

17.53 hr
36%
-

52%

-

477 keV 1409 keV
931 keV

-

55Fe

Figure 6-1. Simplified decay
scheme for 55Decay
Co.
Simplified

2.73 y

Scheme

The production of 55Co using natNi and 58Ni have been performed,6,17 however only the
radiochemical purity was reported and specific activity of the final product was not addressed.
High effective specific activity (ESA) of radiometals is important as metal contaminants have
negative impacts on radiolabelling,21,22 For best radiolabelling results using 55Co, ESA
measurements must be performed and productions optimized so that high-specific activity
material can be obtained.
In this work, the production of 55Co via the 58Ni(p,α)55Co reaction is discussed along with
ESA measurements performed using both DOTA titrations and Ion Chromatography.21 An antiVEGF peptide previously investigated by our group, L19K-FDNB, has been shown to have a
long blood clearance time.23 This property makes this peptide an optimal system for studying the
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stability of different metal chelate complexes in vivo at time points up to 48 hrs. The
biodistribution data for 55CoCl2 and 55Co-NO2A-L19K-FDNB and 55Co-DO3A-L19K-FDNB
were compared at 24 and 48 hrs post injection to establish the in vivo stability of 55Co chelated
with NO2A and DO3A in tumor-bearing mice.

Materials and Methods
Materials
Trace metals grade reagents were purchased from Sigma-Aldrich (USA) and used
without purification and Milli-Q deionized water (18 MΩ cm-1) was used for all dilutions unless
stated otherwise. All glassware and vials were acid washed in 8M HNO3 for 24 hrs prior to use.
DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) was purchased from
Macrocyclics (USA). Two versions of the peptide L19K were synthesized by CPC Scientiﬁc
consisting of the sequence Chelate-PEG4-GGNECDIARMWEWECFERK-CONH2, with a CysCys disulﬁde bridge and polyethylene glycol (PEG) as a spacer between peptide and chelator
where the chelators were either NO2A or DO3A.

58

Ni was purchased from Isoflex (USA) with

99.48% isotopic enrichment.

Targetry and Irradiation
45-55 mg of 58Ni in powder form was plated onto a gold disk by electrodeposition as
previously described by McCarthy et al.24 The electroplating cell was 9 cm in height with an
inner diameter of 1.8 cm. The bottom of the cell consisted of a teflon base that connected to the
gold disk exposing a 5 mm circle. A graphite rod was used as the cathode and stirred the
solution slowly as a voltage of 2.5 V was applied for ~12 hrs. The current remained between 8108

20 mA throughout the process. Targets were irradiated on a 15 MeV cyclotron (CS-15) for 2060 μAhrs. Targets were allowed to sit for two hours prior to processing to allow short-lived
contaminants to decay.

Purification
For processing, targets were placed in 10 mL 9 M HCl and heated with reflux for
approximately one hour in order to dissolve the nickel from the gold disk. Once the solution
cooled it was placed in a 1 cm x 10 cm glass column (Biorad, USA) with 2.5 mg AG1-X8 resin
(Biorad, USA). In order to determine separation conditions, the eluate along with 10-40 mL of 9
M HCl were collected followed by another 10 mL of 0.5 M HCl to elute the 55Co. Fractions of 1
mL were collected and analyzed using an HPGe (High Purity Germanium) detector (Canberra,
USA) and the final 55Co fractions were evaporated to dryness and reconstituted with 20 μL MilliQ water.

55

Co productions were analyzed using Ion Chromatography21 for transition metal

contaminations.

Effective Specific Activity
DOTA titrations were performed in order to determine the effective specific activity of
55

Co productions and the method was adapted from the TETA titration method reported

previously by McCarthy et al.24 1.2 MBq (5 µL) of 55Co was added to eight different
concentrations of DOTA in ammonium acetate pH 5.5 ranging from 4.3 × 10-4 μmol to 6.3 × 10-2
μmol. Final volume was brought to 50 µL using 0.5 M ammonium acetate buffer pH 5.5. The
solutions were placed in an agitating incubator at 37 ºC for 30 min. Solutions were cooled to
room temperature and then centrifuged. A 1 µL sample from each DOTA concentration along
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with 1 µL unbound 55Co was analyzed for the percent 55Co incorporated determined by Thin
Layer Chromatography (TLC) using silica plates and 1:1 mixture of 10% ammonium acetate and
methanol as an eluent. Plates were analyzed using a Radio TLC Plate Reader (Bioscan,
Washington DC). Data was plotted as molar concentration of DOTA vs. % 55Co incorporation.
The curve was fit using a sigmoid plot fit program in Prism (Graphpad, USA). The EC50 value,
concentration of 55Co that bound to 50% of the DOTA molecules, was determined from this fit.
The ESA was set equal to two times the EC50 value.

Animal Models
All animal care was performed as stated in the Guide for Care and Use for Laboratory
Animals by the National Institutes of Health under a protocol approved by the Animal Studies
Committee at Washington University in St. Louis. Female Athymic Nu/Nu mice (National
Cancer Institute, USA) aged 6-9 weeks were anesthetized with a ketamine/xylazine cocktail
(VEDCO, USA). 100 μL of approximately 2 x 107 cell/mL HCT-116 colon cancer cells
suspended in saline were subcutaneously injected into the shoulder. Tumors were allowed to
grow for two weeks before imaging and biodistribution studies.

Small-Animal PET/CT imaging
Prior to imaging, animals were anesthetized with 2% isoflurane. 100 μL of 74 kBq/μL
55

CoCl2 in 0.1 N saline was injected into HCT-116 tumor bearing mice (n=4) via tail vein

injection and imaged using an Inveon MicroPET/CT scanner (Siemens, USA) at 2, 24, and 48
hrs post injection. Static PET images were acquired for 20 minutes. PET data was reconstructed
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using standard methods with the maximum a posteriori probability (MAP) algorithm and coregistered with CT (computed tomography) using image display software (Inveon Research
Workplace Workstation, Siemens, USA). Volumes of Interest (VOI) were drawn using CT
anatomical guidelines.

Biodistributions
100 μL of 74 kBq/μL 55CoCl2, 37 kBq/μL 55Co-NO2A-FDNB, or 37 kBq/μL 55CoDO3A-FDNB in 0.1 N saline were injected into HCT-116 tumor bearing mice.

55

Co-NO2A-

FDNB and 55Co-DO3A-FDNB were prepared and labeled as the 64Cu analogues described by
Marquez et al.23 and with a final specific activity of 3.7 MBq/ug. For each agent, (n=3) mice
were sacrificed at 24 and 48 hrs post injection followed by removal of blood, lung, liver, spleen,
kidney, muscle, fat, heart, brain, bone, tumor, stomach, small intestine (sm int), upper large
intestine (u lg int), and lower large intestine (l lg int). Each organ was weighed and measured for
radioactivity using a gamma counter. The radioactivity was background subtracted, decay
corrected to time of injection and reported as % ID/g (percent injected dose/g tissue).

Statistical Analysis
All data were analyzed using Graphpad Prism version 6 (Graphpad, USA). P values
were calculated using one-way ANOVA to compare more than two groups with one variable. P
values with 95% confidence interval (P < 0.05) were considered significant.
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Results
Production and Purification of High Specific Activity 55Co
58

Ni was plated onto a gold disk with an average efficiency of 95 ± 3 % and thickness of

~300μm. Irradiations produced an average of 6 ± 1 MBq 55Co/μAh which is consistent with
yields predicted by Kaufman.19

57

Ni and 57Co were coproduced at rates of 16 ± 2 kBq/μAh and

11 ± 2 kBq/μAh respectively.
Due to the coproduction of 57Ni, separation could be analyzed by measuring the
characteristic gamma rays of 57Ni (E1=1.378 MeV, I1=81.7% and E2=0.127 MeV, I2=16.7%) and
55

Co (E1=0.931 MeV, I1=75%; E2=0.477 MeV, I2=20.2% and E3=1.409 MeV, I3=16.9%) in each

fraction using an HPGe detector. Elution profiles for 57Ni and 55Co are shown in Figure 6-2.
57

Co contamination was determined by analyzing its characteristic gamma ray 0.122 MeV

(85.6%) in each fraction. Washing the column with an additional 10-40 mL 9 M HCl removed
nickel without significant loss of 55Co. The average recovery of 55Co with a 40 mL 9 M HCl
column wash was 92 ± 3 %.
ESA measured via DOTA titration was found to be 259 MBq/μmol DOTA when washing
the column with 10 mL 9 M HCl. Increasing the column wash to 40 mL resulted in an increased
ESA of 1.96 GBq/μmol DOTA (Figure 6-3). Ion Chromatography measured nickel
concentrations to be 3.5 μmol/μCi and 28 nmol/μCi for 10 mL and 40 mL column washes
respectively. The only radioactive impurity found in the final 55Co fraction was 57Co at 0.2 % of
the total 55Co activity.
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Figure 6-2. Concentration of 55Co and 57Ni in each fraction, as measured using HPGe
detection of the characteristic gamma rays, showing good separation.

Figure 6-3. 55Co-DOTA titration curves demonstrating a seven-fold increase in ESA (259
MBq/μmol to 1.96 GBq/μmol) when washing the column with an additional 40 mL 9 M HCl
acid versus a 10 mL column wash.
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55CoCl Small-Animal
2

PET/CT Imaging and Biodistribution

As an emerging radioisotope, in vivo stability data of different 55Co-chelate complexes
had not been previously measured. In order to determine the in vivo stability of these chelates it
is important to know where free 55Co accumulates in tumor models. The distribution of free
55

Co had not been investigated in tumor xenograft models to our knowledge. HCT-116 tumor

xenografts were imaged (Figure 6-4A) and post PET biodistributions (Table 1) were performed
at 2, 24, and 48 hrs p. i. (post injection) to investigate the distribution of free 55Co in this model.
Interestingly, significant accretion of 55Co occurred in the tumor at each of these time points.
Tumor-to-blood ratios (Figure 6-4B) increased over time, likely due to clearance from the blood
occurring at a higher rate than washout from the tumor implying that 55Co is being retained in the
tumor cells. Tumor-to-blood ratios at 2 and 48 hrs were 0.6 ± 0.1 and 1.9 ± 0.4 respectively
exhibiting a 3-fold increase (P=0.006). High uptake in the heart could be due to the potential of
Co2+ to mimic calcium influx.7,10 Clearance of free 55Co occurred through the liver and kidney
as established by the high values listed in Table 1.
Table 1. 55CoCl2 Biodistribution Data at 2, 24, and 48 hrs p. i.
Organ
2 hr (%ID/g)
24 hr (%ID/g)
Blood
4.5 ± 0.6
1.40 ± 0.04
Lung
4.0 ± 0.3
1.9 ± 0.1
Liver(all)
15.7 ± 0.4
6.2 ± 0.8
Spleen
1.9 ± 0.4
0.82 ± 0.05
Kidney
10.5 ± 1.4
4.4 ± 0.4
Muscle
0.6 ± 0.1
0.37 ± 0.08
Fat
1.5 ± 0.9
0.7 ± 0.4
Heart
4.8 ± 0.4
2.8 ± 0.7
Brain
0.31 ± 0.02
0.17 ± 0.03
Bone
1.3 ± 0.2
0.8 ± 0.1
Tumor
2.8 ± 0.6
1.6 ± 0.2
Stomach
1.1 ± 0.1
1.0 ± 0.2
Sm int
3.6 ± 0.6
1.1 ± 0.2
U lg int
4.3 ± 0.8
1.5 ± 0.1
L lg int
1.9 ± 1.0
2.2 ± 0.3
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48 hr (%ID/g)
0.46 ± 0.05
0.98 ± 0.09
2.7 ± 0.7
0.46 ± 0.04
1.9 ± 0.2
0.17 ± 0.03
0.23 ± 0.05
1.4 ± 0.2
0.11 ± 0.01
0.5 ± 0.1
0.86 ± 0.08
0.5 ± 0.1
0.50 ± 0.04
0.7 ± 0.1
1.2 ± 0.2

Figure 6-4. 24 and 48 hr PET images of 55CoCl2 showing uptake in the tumor and clearance
through the liver, kidney, and intestines (A). Tumor-to-blood ratio exhibits a 3-fold increase
from 2-48 hrs (B).

Stability of 55Co-Chelate Complexes
The stability of radiometal-chelate combinations is crucial when designing new PET
imaging probes. Complexes that are not stable in vivo can lead to the radiometal decomplexing
from the chelate and accumulating in different organs throughout the body increasing
background signal and dose to non-target organs. It has previously been established that
changing the radiometal on peptides can have a drastic effect on the affinity of the peptide to its
receptor.25 Using 55Co to radiolabel L19K-FDNB dramatically decreased the affinity for VEGF
when compared to labelling with 64Cu.23 This decreased affinity and long blood clearance time
presents an optimal model to examine the in vivo stability of 55Co-chelate complexes.
The 24 and 48 hr biodistributions of 55Co-NO2A-L19K-FDNB and 55Co-DO3A-L19KFDNB were compared to the biodistribution of free 55Co (Figure 6-5). These data show that
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both NO2A and DO3A chelates radiolabeled with 55Co exhibit good in vivo stability. This is
ascertained by the low uptake of activity in the liver, lung, heart, bone, stomach, and small
intestine when compared to high uptake of free 55Co in these organs. The difference in uptake is
most notable in the liver (6-fold decrease at 24 and 48 hrs) and the heart (4-fold decrease at 24
hrs and 7-fold decrease at 48 hrs).

Figure 6-5. Comparison of the 24 hr (A) and 48 hr (B) biodistributions of 55CoCl2 with 55CoNO2A-FDNB and 55Co-DO3A-FDNB exhibiting the in vivo stability of 55Co-NO2A and
55
Co-DO3A complexes.
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Discussion
The 58Ni(p,α)55Co reaction is an effective route for producing high specific activity 55Co.
Previously this method was reported using a copper disk17 as opposed to gold, however using
copper as the target backing material could have a negative effect on effective specific activity as
copper has a high affinity to both NOTA and DOTA chelators and would compete with 55Co for
binding. The downside to this reaction is that it has a lower cross section when compared to
other radiometals such as 64Cu and 89Zr, which may limit the availability of this isotope to
facilities that have solid target cyclotron capabilities.
The biodistribution of 55CoCl2 is comparable to those seen for 64CuCl2.26-30 The uptake in
the tumor of 55Co is of interest and should be evaluated further. It is possible that its uptake is
due to the over expression of calcium ion channels often found in cancer cells. As discussed
earlier several studies have shown uptake of 55CoCl2 in ischemic cells and is believed to be due
to 55Co partially mirroring calcium influx.7,10
The in vivo stability of the NOTA and DOTA analogs, NO2A and NO3A, complexed
with 55Co provides the foundation for developing 55Co labeled peptides, antibodies, nanoparticles
and small molecules.

55

Co-NOTA and 55Co-DOTA complexes demonstrate greater stability in

vivo than 64Cu-NOTA and 64Cu-DOTA complexes which could be beneficial in cases where
reduced background signal is desired i.e. liver metastases. Additionally the high positron
branching ratio (4 times that of 64Cu and 3 times that of 89Zr) leads to similar images with a
lower amount of radioactivity administered.
Since the affinity of some peptides is dependent on the attached radiometal it would be of
interest to examine this effect on different peptide models. The anti-VEGF peptide used in this
work exhibited lower affinity than previously measured with 64Cu, however in work done by
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Heppler et al.2 55Co-DOTATOC showed the highest affinity for the somatostatin type two
receptor than any other radiometal measured. Further research as to the structure activity
relationship of these peptide-chelate-metal complexes would be significant for designing
superior PET imaging probes.

Conclusions
Co can be made with high specific activity via the 58Ni(p,α)55Co reaction. The in vivo

55

stability of 55Co labeled NOTA and DOTA derivatives make this radioisotope a promising
isotope for many different applications. Future work should compare the affinity of 55Co labeled
peptides with other radiometals to optimize the best metal-chelate-peptide combination for the
application.
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7.1 Radioisotopes in Medicine
Mother Nature provides us with several radioisotopes that are used for a broad range of
disciplines. In addition to these naturally occurring radioisotopes, many radioisotopes are made
synthetically using cyclotrons, linear accelerators, or nuclear reactors. Medical research employs
almost exclusively synthetic radioisotopes for use in basic science research, imaging, and
therapy.
From 2006 to 2010 the number of nuclear medicine procedures performed annually
worldwide increased from 18 million to well over 30 million.1,2 The growth of nuclear medicine
has sparked an increase in the developments of advanced imaging and therapeutic agents and
more radioisotopes are being used than ever before.3 The desire for different chemistries is
driving the increased demand for radioisotopes of elements not previously used for nuclear
imaging and therapy. The distinctive chemistries and the broad range of nuclear properties of the
many radioisotopes located near the line of beta-stability make for a large playing field of
potential medical isotopes.
In Figure 7-1 the current sources of medical radioisotopes are shown; however, some
desired radioisotopes cannot easily be made by current methods. One such isotope is 67Cu, a
radioisotope of interest for cancer therapy.4,5 To make usable quantities of 67Cu a new method,
isotope harvesting, is being investigated. The majority of the work in this thesis investigates the
feasibility of harvesting 67Cu from an aqueous beam dump at a new national facility.

Figure 7-1. Examples of medical radioisotopes from different sources.
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7.2 Isotope Harvesting Conclusions
The first step in determining the feasibility of isotope harvesting was the successful
design and implementation of an end station that could serve as a mock beam dump. This end
station was constructed and proved to be functional by several collections of 24Na from the water
exposed to an analyzed 24Na beam. The end station proved to be very robust showing very little
radioactive damage from the secondary ion beam.
With this first successful use of the end station, we moved on to an isotope of interest to
medicine, 67Cu. An analyzed 67Cu secondary beam was collected in the water target cell and
followed with the chemical separation of 67Cu. Chemical separations gave an average recovery
of 88 ± 3 % for 67Cu which was in strong agreement with results obtained from preliminary
separation experiments performed prior to the experiment. The final 67Cu product was
successfully used to radiolabel an anti-HER2 antibody Trastuzumab (Herceptin), which
established that the 67Cu obtained from the aqueous beam dump was both in the correct chemical
form and appropriate effective specific activity.
The analyzed 67Cu secondary beam was an idealized case. To better demonstrate the
feasibility of isotope harvesting, collection and separation of 67Cu from an unanalyzed (i.e.
mixed) beam was performed. This collection contained many contaminants, both radioactive
and stable. A separation strategy was designed and implemented and exhibited an average
recovery of 74 ± 4 % for 67Cu with a radiochemical purity of >99%. The resulting 67Cu was used
to radiolabel an anti-EGFR antibody, Panitumumab, and injected into colon cancer xenografted
mice. The tumor uptake of the 67Cu-NOTA-bz-Panitumumab was comparable to that observed
previously by Chang et al.6
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The final specific activity was 20 nCi/μg which is lower than normally observed with
commonly available radioisotopes such as 89Zr and 64Cu. This low specific activity was likely
due to stable metal contaminants as the final 67Cu fraction had high radiochemical purity. The
decontamination factors and the theoretical ratio of the different elements to 67Cu present in the
beam (Table 5-4) suggest that the low specific activity did not result from poor separation of the
beam fragments. The stable metal contamination was most likely introduced to the 67Cu fraction
during the separation processes by some unknown source. Inductively coupled plasma mass
spectrometry analysis of the final fraction will better determine the composition of the
contamination and a method will be developed to eliminate this contamination in future
experiments.

7.3 Future Work
Although we were able to separate 67Cu from a fragmented 76Ge beam with high
radiochemical purity, there is still more work to be done before the true feasibility of harvesting
this radioisotope can be determined. The first challenge to be addressed is the separation of 67Cu
from a fragmented uranium beam. It is estimated that 60% of the primary beams used at the
Facility for Rare Isotope Beams will be uranium, which will require a more complicated
chemical separation scheme to achieve good radiochemical purity and effective specific activity.
The second challenge is the use of mixed bed resin. The aqueous beam dump at FRIB will
constantly be circulated through a column of mixed bed resin. Experiments should be performed
to observe the amount of 67Cu that binds to this resin along with determining an elution protocol.
Modifications are currently in progress to continuously circulate the water in the target cell
through a column of mixed bed resin.
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Experiments exploring the potential of harvesting other radioisotopes of interest would
also be essential for the evaluation of the feasibility of isotope harvesting from FRIB. To make
isotope harvesting a reality, examples of successful separations of several different radioisotopes
of interest to a variety of fields should be provided. A proposal to collect secondary beams
containing 48V and 85Kr at the NSCL has been accepted and the experiments are likely to start
sometime next year. The harvesting of 67Cu from the aqueous beam dump, as described herein,
can serve as a scaffold from which separation strategies for the above radioisotopes in addition to
those listed in Table 1-2 can be built.
In conclusion, the work presented here provides a strong foundation for the harvesting of
67

Cu from a heavy-ion fragmentation facility. Radioisotope users from different fields would

benefit from isotope harvesting at the future FRIB facility. While much more work still needs to
be performed for 67Cu and each radioisotope will present its own challenges, isotope harvesting
appears to be a promising pathway to radioisotopes that are not currently available in usable
quantities by conventional methods.
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Glossary of Terms

Antibody: An antibody is a protein produced by the body's immune system against an antigens.
Antigen: A foreign substance that, when introduced into the body, is capable of stimulating an
immune response.
Becquerel (Bq): Unit to measure radioactivity. 1Bq = 1disintegration/second
Catabolism: The set of metabolic pathways that breaks down molecules into smaller units to
release energy.
Curie (Ci): Unit to measure radioactivity. 1Ci = 3.7x1010Bq (d/s)
DOTA: 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid
EC50: The concentration of a drug that gives half-maximal response.
Effective Specific Activity: The amount of radioactivity per unit mass of competing metal for a
certain chemical or biological reaction.
High-Performance Liquid Chromatography (HPLC): A high pressure system which employs
a column and solvents to separate components of a solution.
Immunoreactivity: Measurement of the retained functionality of the antibody after conjugating
with a chelator.
Inductively-Coupled Plasma Mass Spectrometry (ICP-MS): A mass spectrometer that is
commonly used in elemental analysis.
Ion Chromatography (IC): An high-performance liquid chromatography method to separate
several different first-row transition metals.
Magnetic Rigidity: The momentum per unit charge of a particle (p/q). The units of magnetic
rigidity are Tm (tesla meters).
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NOTA: 1,4,7-triazacyclononane-N,N',N"-triacetic acid
Particle nanoamps (pnA): Number of particles per nanoamp of beam (pnA is equal to nA for
H+ or H- beams)
PIXE: Particle Induced X-ray Emmission, a method used in elemental analysis.
TETA: 1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetraacetic acid
Theoretical (Maximum) Specific Activity: The amount of radioactivity per μmol of the
radioactive species (e.g. activity of 64Cu per μmol 64Cu).
True Specific Activity: The amount of radioactivity per μmol of atoms of the same element
(e.g. activity of 64Cu per μmol copper).
Xenografts: Cells from one species transplanted into an organism of another species (i.e. human
cells into mice).
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